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ABSTRACT
Electrically-responsive biomaterials such as conductive polymers and conductive
hydrogels have piqued the interest of scientists for targeted payload delivery
applications in recent years since generating electricity is easy. Conductive composite
hydrogels are a specific class of hydrogel that can be designed to not only have
mechanical properties similar to skin and soft tissue, but can also have electrical
properties comparable to metals and organic semiconductors. These composite
hydrogels have been considered for a wide range of technological applications.
Conductive hydrogels can be fabricated to ensure that they exhibit: 1) excellent
biocompatibility; 2) soft and tunable mechanical properties similar to biological tissue;
3) mixed electronic/ionic conductivity that promotes efficient signal transduction for
delivering drugs to the tissue; 4) ability to create materials with well-controlled
microstructure; and 5) ability to be loaded with wide range of molecular size
molecules with different molecular charge; thereby making conductive hydrogels a
stronger tool for targeted delivery applications.
This dissertation focuses on describing a novel method of creating hydrogel
composites from the commercially available conductive polymer PEDOT (poly(3,4ethylenedioxythiophene):polystyrene sulfonate). The resulting method allows for fast
production of conductive hydrogels, and does not need specific equipment. In this
method of production, a wide range of mechanical properties can be achieved by
altering hydrogel composition and production temperature without jeopardizing the
electrical properties of the hydrogels by using conductive polymer. Additionally, this

method could be employed for fabrication of conductive composite hydrogels with a
variety of polymers and cross-linkers.
Chapter two provides an overview on electrically-responsive targeted delivery
depots with respect to their release mechanisms from electrical stimulation, parameters
affecting drug release with electricity, and current efforts on multi-drug delivery using
electrically-responsive materials.
In chapter three, we explored the production and application of pAAc-PEDOT
(poly acrylic acid-poly(3,4-ethylenedioxthiophene):polystyrene sulfonate) cryogels.
Our goal was to develop soft, injectable, and conducting hydrogel-based electrode
materials, and to characterize their sustained mechanical and electrical properties
before and after sterilization and injection. Biocompatibility, cytotoxicity, and drug
delivery capability of these cryogels were also investigated. pAAc-PEDOT cryogels
were made at a subfreezing temperature to generate a macroporous structure within
the gels. The resulting porous hydrogels exhibited enhanced mechanical properties.
The cryogels exhibited softness (0.2-20 kPa), excellent toughness, and strain of
failure, and could survive injection through 16-gauge needle. Additionally, these gels
demonstrated the capability of recording alpha oscillations. Last but not least, these
cryogels were found to be biocompatible and were capable of being loaded with and
delivering proteins.
In chapter four, we investigated the integration of conductive hydrogels (alginatePEDOT) with tripolar concentric ring electrodes (TCREs). Our goal was to develop
hydrogel-integrated electrodes with isolated channels to improve the quality of
recorded signals. To this end, we fabricated alginate-PEDOT hydrogels and explored

their mechanical and electrical properties to identify an optimized hydrogel
formulation. We also investigated the channel isolation of our proposed electrode
design. Furthermore, we used our novel electrode to record neural activity and
compared recorded signals of hydrogel TCREs with those of conductive paste.
Chapter five provides overall conclusions for this dissertation as well as
comments on potential future work.
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PREFACE

This dissertation is written in manuscript format in accordance with University of
Rhode Island Graduate School Guidelines. There are five chapters included in this
dissertation. The first chapter is the instruction and motivation to this work. The
second chapter, entitled “Electrically-Responsive Targeted Delivery Depots“ is part of
an invited review paper in preparation to be submitted to “Acta Biomaterialia.” The
third chapter, entitled “Cryogel-Based Electronic-Tissue Interface with Soft, Highly
Compressible and Tunable Mechanics” is under review in “Advanced Health Care
Materials.” The fourth chapter, entitled “Integration of Conductive Hydrogel into
Tripolar Concentric Configuration to Improve Channel Isolation“ is prepared to be
submitted to “Advanced Health Care Materials.“ The fifth chapter includes the
conclusions and future work related to this dissertation.
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CHAPTER 1

1. Introduction and Motivation
Neuroprosthetic devices have been developed in order to return function, or to
reduce symptoms exhibited by patients suffering from neurological diseases [1]. For
instance, electrical therapies such as cochlear implants [2, 3] and deep brain
stimulation [4, 5] are promising strategies in treating patients with neurological
diseases. While promising, these strategies are not without limitations [1]. For
example, the strategies require sustained tissue-electrode interface over time [6] and
the electrodes must minimize overpotential at the tissue-electrode interface, and
maintain a conductive path between the electrode and the tissue being stimulated.
Traditionally, metallic electrodes have been used for stimulation of neural tissue.
Despite their outstanding electrical properties over short periods of time, metallic
electrodes do not maintain these properties over long periods of time [7]. In addition,
introduction of these electrodes to patients requires invasive surgery that often
ruptures neurons and blood vessels and activates a foreign body response at the site of
electrode tissue interface [1]. Additionally, the mismatch between the mechanical
properties of the electrode and tissue can cause shear stress at the interface, which can
in turn result in prolonged inflammation at the site of electrode, and eventually the loss
of connection between the electrode and surrounding tissue [8-11]. These constraints
pose limitations for the application of the commonly-used electrodes over extended
periods of time.
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Electroencephalography (EEG) is an affordable, non-invasive technique used to
measure electrical impulses generated by brain activity. The EEG has excellent
temporal resolution, which is ideal for diagnosing neurological diseases. For example,
EEG is currently used for diagnosing diseases such as epilepsy and head trauma [12,
13]. Furthermore, it is extensively used in neuro-rehabilitation applications such as in
the brain-computer interface to help control the movement of prosthetic limbs in
patients with paralysis. [14-17]. However, while EEG has an excellent temporal
resolution, it has a limited spatial resolution. Because of the aforementioned benefits
offered by EEG, several methods, such as surface Laplacian, have been designed to
improve the spatial resolution of EEG. Surface Laplacian methods not only enhance
spatial selectivity, but also attenuate universal noise and improve signal-to-noise ratio
[16, 18-23]. Several electrodes have been designed based on surface Laplacian theory,
which have a center disc and one or more rings around the center disc [18, 24]. These
electrodes are often made of metals, which require electrical connections with the
scalp. To successfully make a connection between electrodes and a patient’s skin,
conductive paste is typically used [25]. While conductive paste significantly improves
the electrode-skin interface, it also partially electrically shorts the channels of
electrodes and affects the quality of recorded signals. Moreover, conductive paste
dries out over time, negatively affecting the quality of signal and increasing noise over
time. These obstacles limit the application of conductive paste where EEG
spatiotemporal resolution over time is vital. Given the constraints of EEG-based
neuroprosthetic devices with respect to their current methods and the limitations of
their applicability, we aimed to develop a novel biomaterial system that can provide an
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effective electrical connection between the scalp and electrode, be formed into a
desired shape for the given application, and retain its integrity for long periods of time.
To address the aforementioned issues, we first aimed to develop an improved
conductive interface between tissue and the electrode using conductive hydrogels.
Hydrogels are soft materials made from cross-linked hydrophilic polymeric networks
[26]. Although hydrogels themselves are insoluble in water, they can preserve a large
fraction of water within their network for prolonged periods of time while successfully
retaining their 3D structure [27]. Conductive polymer hydrogels are a unique class of
hydrogels, which not only have similar mechanical properties to tissue [28], but also
have similar electrical properties to metals and inorganic semiconductors [29]. There
are currently several conductive polymers available, which have been widely used for
fabricating conductive hydrogels [30]. It has been demonstrated that the conductive
polymer poly(3-4, ethylenedioxythiophene) (PEDOT) provides better conductivity and
stability in oxidized environments than other widely used conductive polymers [3136]. Moreover, PEDOT is biocompatible [37]. Thus, for the purpose of this study,
PEDOT was used as the conductive component of the electrically conductive
hydrogel.
PEDOT is a conjugated polymer with an outstanding chemical stability [30, 38]
owing to the fact that the EDOT monomer has only two reactive hydrogens, which
means that it is unlikely to have chemical defects in the PEDOT chain [39]. PEDOT is
commonly used in its oxidative state where some of electrons are removed from main
chain, generating positive carriers, and thus makes the polymer electrically conductive
[40]. Although PEDOT is not soluble in water, it is possible to form an aqueous
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suspension by doping it with different types of anions such as poly(styrene sulfonate)
(PSS) [39]. PEDOT and its water soluble PEDOT:PSS are the most commonly used
conducting polymers [38].
For the resulting injectable conductive hydrogel systems, we employed a shape
memory technique during hydrogel synthesis by fabricating the hydrogels at a
subfreezing temperature, which results in hydrogels with interconnected macropores
[41]. The ability of the hydrogels to maintain their shape can allow for minimally
invasive implantation of the gels at the application site [42]. The novel method of
conductive hydrogel fabrication used in the described studies utilized a commercially
available conductive polymer, which allows for fast production without the need for
special equipment. In addition, the resulting synthesis methods could be possibly used
to fabricate conductive hydrogels with variety of polymer types for a wide variety of
applications.
While PEDOT hydrogels have been created previously, they have yet to be
employed as a means to enhance the spatial resolution of multi-channel electrode
systems by providing soft, 3D conducting structures that retain their shape and
moisture over prolonged periods of time. Thus, the work proposed here is a novel step
forward in the context of contemporary technologies related to neuroprosthetics.
Overall, we hypothesized that by integrating the conductive polymer PEDOT
within a hydrogel network and designing the morphology of the resulting conductive
hydrogels based on the given application, that a sustained conductive interface
between the electrode and tissue can be achieved.
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CHAPTER 2

Electrically-Responsive Targeted Delivery Depots

2.1 Introduction
Electrical stimulation can be used for a variety of treatments such as pain
management [1-4], neuromuscular dysfunction [5], strength training [6], improving
local blood flow [7], motor control and retardation of muscle atrophy [2, 8, 9],
improving joint mobility [10], tissue repair [9] and wound healing [11-13], and acute
and chronic edema [14-17]. Electrical stimulation has also been used for drug delivery
[18], brain computer interface (BCI) [5], deep brain stimulation [19], cochlear
implants [20, 21], transcranial direct current stimulation (tDCS) [7], etc.
Stimuli-responsive biomaterials have garnered great interest in recent years for
their use in drug delivery applications [25]. Although many delivery systems have
been developed that can respond to electromagnetic fields, light, ultrasound, or pH
[23-25], activating these systems requires the use of large and specialized devices. On
the other hand, generating electric stimuli typically does not require large or
specialized equipment [26, 27]. Moreover, designing and miniaturizing the type of
equipment required for applying electrical stimulation is an advantage [28] of using
electrical stimulation for drug delivery applications. Hydrogels serve as drug
reservoirs where drugs can be physically entrapped within hydrogel network [29, 30],
have electrostatic interactions with hydrogel network [31-33], or bind with conductive
polymers [34-36] and nanoparticles [27,31,37, 38].
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Electrically stimulated drug delivery systems are platforms that allow localized
and on-demand drug release for a variety of applications [39]. For example, electrical
pulses can enhance membrane permeability in drug delivery systems [40-42], and can
allow for the delivery of large molecules such as peptides, proteins, nucleotides [43,
44], and therapeutic agents such as insulin and chemotherapeutics, which often face
difficulties in being released from biomaterials [27, 45]. Electrical stimulation of
membranes loaded with these therapeutics could enhance effective drug delivery by
enhancing membrane permeability [46]. The application of electroporation
(electropermeability) has been used to develop a new cancer treatment modality,
known as electrochemotherapy, over the past two decades [45]. Moreover, drug
delivery systems have been employed for the delivery of therapeutics for treatment of
diseases such as Alzheimer's disease [39] and epilepsy [47], which require the delivery
of agents able to overcome the low permeability of blood-brain barrier.
Locally delivering therapeutics to tissues has been a challenge for a long time.
One of the methods used to address this is the design of drug-loaded microchips and
their implantation in the vicinity of the tissue needing access to the therapeutics.
Microchips provide excellent local and on-demand release of single or multiple drugs
and they can deliver a multitude of therapeutic forms, including liquids, solids, and
gels [48-50]. The downside of using microchips is that they require invasive surgery
for implantation, and implanting microchips for a prolonged time could cause
inflammation at the implantation site. Moreover, microchips have a low-capacity
reservoir (<1 μL) [51]. When higher dosage of drug needs to be delivered, it requires a
microchip with a larger reservoir, which can be expensive [26]. To overcome these
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issues, conductive hydrogels [34, 52], conductive polymers [39, 53, 54], and
conductive sol-gels [14] have been developed as electrically-responsive drug delivery
depots.
For drug delivery with electrical stimulation, direct current (DC) stimulation is
commonly used to apply an electric field [55]; however, DC stimulation can be a
potential physical and electrical hazard to the skin and tissue at the site of the
electrode-tissue interface. Temperature, acid/base, or other types of chemical burns
may cause skin irritation, burns, and in extreme cases when tissue is exposed to an
electric field for a prolonged period of time, causes tissue necrosis [56]. As a result,
local temperature, pH, and electrode overpotential needs to be monitored to avoid
tissue irritation and local burns. In addition, using a safe electric current density and
duration and conductive paste can minimize the side effects of electrical stimulation
[37, 55, 56].
While exposing tissue to electric fields for prolonged periods can increase the
risk of burn and tissue necrosis due to local changes in temperature and pH [55],
controlled local increases of temperature via electrical stimulation, known as
radiofrequency ablation, has been used [57]. In this method, electrodes are inserted
inside tissue in order to induce controlled tissue necrosis for the treatment of a variety
of diseases, including cancer [57, 58]. Moreover, radiofrequency ablation can be
combined with chemotherapy, allowing for chemotherapeutic agents to be released in
the vicinity of the heated area to enhance the effect of the chemotherapeutic agent [5759].
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2.2. Release mechanisms from electrical stimulation

2.2.1 Drug release by pressure
When a DC electric field has been applied to hydrogels between electrodes, it
induces anisotropic deformation and ion shift in the hydrogels [60], which causes
mobile ions to move toward the counter-electrode, causing local pH and osmotic
pressure changes. As a result, the hydrogels shrink when pressure is increased and
swell when pressure is decreased [60-64], and consequently, the pressure on the anode
side is not the same as the pressure on the cathode side [65-68]. Additionally, free ions
in the surrounding solution move toward the counter-electrode and move into the
hydrogel network [69, 70] (Figure 2.1). A uniaxial stress gradient, caused by
electrostatic forces, plays an important role in the deformation of hydrogels [61, 65,
71], and these deformations are reversible so that once an electric field is removed the
hydrogel regains its original shape [29, 69, 72]. A change in pH within a hydrogel can
result in a volume change (swelling [37, 47], shrinkage/deswelling [29, 56, 66, 73]), or
deformation (bending) [42, 69, 74, 75]) depending on the hydrogel charge and
surrounding electric field strength. As a result, a pH change in the hydrogel at the site
of a working electrode could result in drug release [31].
Both pH changes and deformation can contribute to the release of drugs from
hydrogels. For neutral drugs, one primary mechanism is involved in drug release - the
deformation of the hydrogel matrix at the working electrode [66]. However, for
charged drugs, three mechanisms are involved in drug release: ion exchange,
swelling/deswelling/bending (deformation), and electro-osmosis from anode to
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cathode or vice versa depending on the electric field direction [67]. Figure 2.2
demonstrates the effect of electric field application on drug release. When the electric
field is off, there is no matrix deformation, volume change, or drug release (Figure
2.2A). As soon as an electric field is applied the matrix shrinks (Figure 2.2B) or swells
(Figure 2.2C) depending on the hydrogel properties, allowing for effective release of
the imbibed drugs.
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Drug
H2 O
Figure 2.1. Hydrogel deformation that occurs when an electric field has been applied.
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A

B

Electric field
off

Electric field
on

Deswelling/shrinkage

C

Swelling

Figure 2. Matrices deform and drug releases once an electric field is applied.
Representative hydrogel microstructure with (A) no electric field, (B) electric field
applied with matrix shrinkage, (C) electric field applied with matrix swelling.

2.2.2 Drug release by matrix degradation
Electrical stimulation of hydrogels can result in the migration of ions towards
the counter-electrode, which can result in localized changes in pH. As a result, a
change in pH can cause matrix degradation and drug release [76-80]. Moreover, the
rate of drug release depends on pH, where the drug release rate is higher at lower pH
and decreases when the pH increases [76]. Figure 2.3 illustrates the degradation of a
hydrogel matrix when an electric field is applied, and Figure 2.4 demonstrates how
polymer weight loss can occur when an electric field is applied.
16

B

A

Electric field
off

Electric field
on

Figure 2.3. Schematic of hydrogel degradation and drug release upon applying
an electric field. (A) no electric field is applied and no drug release occurs, and (B)
degradation and drug release occurs as a result of an applied electric field.
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Time (h)

on
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Figure 2.4 Surface erosion of a matrix can occur upon applying an electric field.
Graphs show weight loss of poly(ethyloxazolion)-poly-(methacrylic acid) complexed
in 0.9% saline when 10 mA current is passed with a (A) continuous current or (B)
step-function electric current [70].
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2.3. Parameters affecting drug release via electricity
For electrically-controlled drug release from biomaterials, sol-gels [81, 82],
hydrogels [66, 76], and conductive polymers [35, 83] have been used as drug
reservoirs. For typical drug delivery systems, hydrogels are more common than
conductive polymers, since conductive polymers have certain limitations and are only
needed in certain applications. For example, only charged drugs with certain sizes can
be released from biomaterials using electrical stimulation [52, 84]. Hydrogels offer
many advantages in drug delivery applications including their tunable mechanical
properties, biocompatibility, biodegradability, and high water content [28, 62, 68].
Additionally, the three-dimensional structure of hydrogels allows for the
immobilization of large molecules such as protein, peptides, and DNA-based drugs
[85, 86]. Unfortunately, hydrogels on their own typically exhibit poor electrical
behavior [87]. One type of hydrogel that can be used to overcome this limitation is
electrolyte hydrogels, which can be used for controlled released [37, 64, 66]. In
addition, materials can be incorporated into hydrogel to improve their conductivity.
These materials include conductive polymers [30, 35], conductive polymer
nanoparticles [78, 81], carbon nanotubes [56, 88], dielectric nanoparticles [30],
graphene [89] and metal nanoparticles such as silver [90]. In addition to enhancing
conductivity these materials can also reduce diffusion of drug from hydrogel [37], and
thus this limitation needs to be taken into consideration when designing electricallyconductive hydrogel systems for drug delivery applications.

2.3.1 Effect of drug charge and size
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Adequate characterization of the molecular interaction of matrices with drugs
is critical for developing an effective and reliable electrically-stimulation drug
delivery system. One of the most import factors that needs to be taken into
consideration in the design of matrix formulations is drug charge [32, 66, 70].
Although the delivery of ionic drugs is common with electrical stimulation, non-ionic
drugs also can be loaded to matrixes for this application, but often at lower
concentrations than ionic drugs. The molecular interactions between charged drug and
charged matrix can increase the loading capacity of hydrogels [70]. In addition, drug
release rates decrease with increasing drug size [32] and Figure 2.5 demonstrates that
larger drug sizes results in lower drug release rates.

Figure 2.5 Drug release rate decreases with increasing drug size. Tannic acid has
the largest size and therefore has the lowest release rate. Benzoic acid has the smallest
size and hence has the highest release rate. Benzoic acid Mw = 122. Folic acid Mw =
441, tannic acid Mw = 1701 [32].
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2.3.2 Effect of matrix concentration and cross-linking
Increasing matrix concentration and charge will enhance its response to
electric fields [64, 91], thereby impacting the release of drugs from the systems.
Another factor that can affect the release rates of drugs from matrixes is the crosslinking ratio of the hydrogel systems. Increasing the cross-linking ratio decreases the
porosity of hydrogel resulting in a decrease in the drug release rate [34, 92-05]], as
shown in Figure 2.6. Increasing the cross-linking ratio also decreases molecular
mobility with in the hydrogel matrix [96]. Polymer molecular weight affects the crosslinking ratio of hydrogel systems, where shorter molecular weight chains result in
larger free volumes and chain ends within the hydrogels [75]. In addition, increasing
cross-linking density improves the mechanical properties of hydrogels [96].
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Figure 2.6. Increasing the cross-linking ratio in hydrogels decreases the rate of
drug release. Amount of folic acid released from alginate-calcium (Alg-Ca) hydrogels
with 0.3, 0.7, and 1.3 cross-linking ratios [32].

2.3.3 Effect of adding conductive materials
Hydrogels that are responsive to electrical stimulation are sometimes known as
electrolyte hydrogels [64]. In general, the addition of conductive agents to electrolyte
hydrogels will enhance their conductivity [34, 56, 62, 80, 82, 91] and after electrical
stimulation, increase drug release [34, 62]. Samples with higher conductivity can
deform more significantly, which can result in enhanced drug release [56, 73, 98].
Despite these advantages, there is a limit for increasing the amount of conductive
additives to hydrogels, as increasing too much can result in sedimentation of the
conductive agent [56, 73, 99], or not significantly improve the conductivity of the
hydrogel system [62]. Moreover, high loading of a conductive agent can result in
increased cross-linking between the polymer chain added agent, thereby restraining
chain movement so that the hydrogel exhibits a smaller mesh size, less swelling, and
hence a minimized drug release rate [34, 68, 100]. If a large amount of conductive
nanoparticles are loaded into a hydrogel, they have the potential to allow for a burst of
drug out of the hydrogel and/or result in local damage to the matrix due to stress of
removing the electric field (due to matrix deformation while electric field is applied).
For multi-pulsatile release profiles, it is imperative to choose a conductive agentpolymer ratio which prevents diffusion [62] and allows for the constant release of drug
during stimulation without damaging the matrix [56]. Figure 2.7 demonstrates the
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effect of adding conductive agent to hydrogel on drug release rates and Figure 2.8
shows the effect of adding graphene and carbon nanotubes to hydrogels on mechanical
and electrical properties.

A

B

Figure 2.7. Increasing the amount of conductive agent enhances the drug release
rate. (A) Pulsatile drug release from a hydrogel upon applying electric field. Drug
release was monitored while applying an electric field for 5 minutes every 60 minutes.
The pulsatile release of C-sucrose was determined for blank hydrogels and hydrogels
with 0.05 mg/ml, 0.1 mg/mls and 0.2 mg/ml of pMWNT (pristine multi-wall carbon
nanotubes). (B) C-sucrose release rates from the described hydrogels. Rates of release
were calculated over time upon exposure to 10 V DC electric field [56].
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A

B

Figure 2.8. Adding conductive agents to hydrogels enhance their mechanical
properties and improves their electrical properties. (A) Stress-strain curve for an
acrylic acid hydrogel with and without graphene. Increasing the amount of graphene
particles in the hydrogel increases hydrogel stiffness and toughness [65]. (B)
Electrical properties of poly(methacrylic) acid hydrogel improves with the addition of
carbon nanotubes, where increasing carbon nanotube concentration decreases
resistance [59].

2.3.4 Effect of electric field polarity
Electric field polarity is one the most important factors in the controlled release
of drugs from electrically-responsive materials. Electric fields generate a driving force
that enhances drug release by generating electro-repulsive forces between the drug and
electrode with the same charge, which increases the rate of drug release [28, 32, 34,
84, 88]. Pairatwachapun et al. showed that the release rate of a positively charged drug
is the highest when a cathode (negatively charged electrode) is placed on the hydrogel
and in comparison, to an anode (positively charged electrode). Similarly, Niamlang et
23

al. [84] demonstrated that the drug release rate of a negatively charged drug is highest
under a cathode. Figure 2.9 shows the release of a negatively charged drug under a
cathode and anode. The negatively charged electrode generated electro-repulsion
forces towards the negatively charge drug, and consequently had a higher release rate.

Figure 2.9. Drug release in response to electrical stimulation of opposite polarity.
Release of benzoic acid from a benzoic acid-loaded poly(vinyl acid) hydrogel in
relation to time with samples exposed to a cathode or anode [33].
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2.3.5 Effect of electric field strength
Electric field strength has a significant impact on drug release from
electrically-responsive hydrogels, where increasing voltage can result in an increase in
the drug release rate [32, 33, 51, 56, 92, 94, 99, 102]. The deformation of conductive
hydrogel matrices depends on the electric field intensity and hydrogel charge. With
increasing voltage, deformation increases [42, 69, 74]. Increasing electric field
strength can increase the shrinkage at the anode site and swelling at the cathode site,
which both result in increased drug release rate [33, 67, 94]. Figure 2.10 demonstrates
the effect of increasing electric field strength on drug release rate, where increasing
voltage resulted in an increase in the drug release rate.

Figure 2.10. Drug release rate increases with increasing electric field strength.
Drug release from poly(AA-co-AMPS)/carrageenan/RGO (poly(acrylic acid-co-2acrylamido-2-methyl-1-propanesulfonic acid)/carrageenan/reduced graphene oxide)
hydrogels with different electric field strengths. Samples was placed between parallel
electrodes 500 mm apart [62, 68].
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2.3.6 Effect of duration of an applied electric field
Increasing the exposure time of matrixes to electric fields can enhance drug
release [29, 35, 92]. At the same time, increasing the duration of an applied electric
field can result in an increase in temperature, especially for a hydrogel network with
high impedance [56]. Any increase in temperature above 41-42 °C during electrical
stimulation can induce tissue necrosis and should be avoided [89]. Seravant et al.
showed that by adjusting strength and duration of an applied electric field, the
temperature increase could be controlled to minimize its effect on the environment
surrounding the implanted hydrogel. Fortunately, drug release from electricallystimulated hydrogel matrices can be fast. For example, drug release can be
successfully achieved upon applying an electric field of 1 V for 10 seconds [78].
Carbon nanotubes exhibit excellent thermal conductivity and exposing a carbon
nanotube-loaded hydrogel to a DC electric field (10 V for 2 minutes) resulted in an
increase in temperature up to 15 °C in the bulk hydrogel [89].

2.3.7 Effect of pH
Solution pH affects the release rate of drugs from hydrogels, where negatively
charged drugs exhibit a higher release rate at higher pH (pH = 8) than neutral or
positive states (pH = 5) due to electro-repulsion forces [88]. For systems that are pHsensitive, drug release solely depends on an applied electric field at neutral pH [99].
As mentioned earlier, electrical stimulation can result in pH changes in a hydrogel
system, where the pH change occurs locally around electrode and not in the bulk of
the hydrogel. pH changes in hydrogel systems should be monitored, since an increase
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in pH above 13 can result in tissue necrosis [37]. To avoid tissue damage, electric field
strength and application time should be monitored closely, where with increasing
applied voltage, exposure time should be decreased [37].

2.3.8 Effect of direction of electric field
Strain in hydrogels following deformation is due to the pressure and therefore
this effect is isotropic. As a result, drug release from hydrogel does not depend on the
direction of an applied electric field and it can be applied from any direction [106].

2.3.9 Effect of porosity and mesh size
Larger pore sizes in hydrogels enhance drug and ion mobility in and
throughout the hydrogel matrix [64, 79, 107], and as a result the quantity of drug
released is higher from hydrogels with larger pore sizes. Larger pore sizes can be
obtained within hydrogels by using a smaller crosslinking ratio [33, 34, 84, 92]. Figure
2.11 demonstrates the correlation of drug diffusion from a hydrogel with the hydrogel
mesh size and cross-linking ratio, where drug diffusion is enhanced by increasing the
mesh size and diffusion decreases by increasing the cross-linking ratio.
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Figure 2.11. Diffusion increases with increasing mesh size and decreases
with increasing cross-linking. Diffusion coefficient of benzoic acid from poly(vinyl
alcohol) hydrogels in relation to mesh size and cross-linking ratio without presence of
electric field [33].

2.3.10 Effect of diffusion
Depending on drug and hydrogel/polymer interactions, passive diffusion of the
drug from the hydrogel matrix can occur [62, 84]. In order to eliminate passive
diffusion of drugs from hydrogel networks and to improve on-demand drug delivery,
dopants have been added to a wide variety of hydrogel systems. Conductive polymer
nanoparticles [31, 78, 81] and carbon nanotubes have been used to prevent passive
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drug release and improve on-demand drug release from drug depots [31, 78, 81].
Figure 2.12. demonstrates that by encapsulating a drug into conductive nanoparticles,
passive diffusion (cumulative release) of the drug from matrix can be prevented. Drug
release rate from dopants depends on the molecule size and exposure time [31].
Increasing dopant concentration will increase release rate up to a point, and increasing
it beyond a certain concentration will no longer enhance release [61].

Figure 2.12. Cumulative release (c.r.) from hydrogel can be prevented by
encapsulating drug with nanoparticles. Cumulative release is observed from
hydrogel with nanoparticles of polypyrrole [81].

2.3.11 Effect of applying electric field on tissue permeability
Electrical stimulation of tissue can increase the permeability of skin. Figure
2.13 shows a schematic of how cell permeability is altered by applying an electric
pulse [40, 41, 94, 108]. When an electric pulse is applied to the skin pores are
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generated in the cellular membrane, allowing for the penetration of drugs through the
membrane [46], which provides a unique opportunity to introduce large therapeutic
molecules into tissue [40, 109]. Skin acts like an ion exchange membrane when it
comes to the diffusion of drugs through the skin, where negatively charged molecules
diffuse more slowly than positively or neutrally charged molecules. Overall, skin
permeability will increase with increasing surface negative charge [34, 108]. Figure
2.14 demonstrates the effect of increasing electric field strength on drug permeation,
whereas the electric field strength increases, drug permeation increases. Additionally,
increasing the amount of conductive agent present in a drug delivery vehicle can
increase skin permeability [108]. Figure 2.15 shows the effect of increasing the
amount of conductive agent in a hydrogel system on the penetration of a drug through
the skin, where by increasing the charge of a lipogel, skin penetration increases.
Electrotherapy also can be used to neutralize or destroy the active sites of
growth factor enzymes. This application is important in that the concentration of
growth factors is exponentially higher in cancerous cells in comparison to healthy
tissue. In addition, low density DC electrotherapy can halt cell proliferation [110]. For
example, electrical stimulation of skin can destruct the stratum corneum, and the cell
structure becomes loose, thereby increasing cell infiltration in the dermis and
degenerating skin appendages, which results in an increase in skin permeation [94].
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Figure 2.13. Electrical stimulation increases porosity of the cellular membrane by
generating pores. (A) Drug cannot diffuse into cell due to drug size (no electrical
stimulation). (B) Pores form in cell membrane and drug enters following electric
stimulation. (C) Membrane reforms once electrical pulse is removed and drug can no
longer penetrate.

31

Figure 2.14. Increasing electric field strength can enhance drug permeation
through skin. Effect of current strength on permeation of ketoprofen through skin
[94].

Figure 2.15. With increasing surface charge skin permeation increases. In vitro
skin permeation profiles showing ascorbyl palmitate by cathodal transport. ● neutral
hydrogel,

○ 10% DCP

(dicetylphosphate)

negative lipogel,

▼20% DCP

(dicetylphosphate) negative lipogel [108].

2.3.12 Biocompatibility
Biocompatibility is an essential requirement for biomaterials used for
controlled drug delivery applications [86]. High cell viability and proliferation can
show that biomaterials are biocompatible [28, 62, 68, 111]. Figure 2.16 shows how
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hydrogels have the potential to be biocompatible since cell viability and proliferation
on the hydrogels is high and that all samples maintained their normal cellular
metabolism. Histology testing on tissue surrounding hydrogels with and without
applying an electric field has demonstrated that hydrogels can be biocompatible [56,
68, 80]. For example, Figure 2.17 shows the potential for hydrogels to be
biocompatible upon implantation. Since pH changes were only observed in the
vicinity of electrodes and not in the surrounding tissue, these changes do not
significantly affect cell growth [37]. Additionally, hydrogels can provide a substrate
for cell adhesion and growth [82, 103, 104] making them physiologically reliable
biomaterials for long-term pulsatile drug release [21].

A

B
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Figure 2.16. Conductive hydrogels are biocompatible, and cells maintain normal
cell metabolism in direct contact with conductive hydrogels. (A) Cell proliferation
of L929 cells exposed to conductive hydrogels and TCP (mean for n = 4

standard

deviation). (B) Live/dead staining of L929 cells at successive culture periods for
CP/OD1, CP/OD3, CP/OD5, C/OD and TCP, respectively. C/OD (chitosan/oxidized
dextran), CP/OD1 (chitosan-graft-polyaniline/1 wt % oxidized dextran), CP/OD3
(chitosan-graft-polyaniline/3 wt % oxidized dextran), CP/OD5 (chitosan-graftpolyaniline/5 wt % oxidized dextran) and TCP (tissue culture plate) [28].

A

B

C

D

Figure 2.17. Conductive hydrogels are biocompatible. Figure (A) and (B) show the
formation of a conductive hydrogel with 1 wt % polypyrrole nanoparticles after
subcutaneous injection in FVB mice. Black arrow indicates implants after (A) one
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week and (B) two weeks post implantation. Figures C and D demonstrate hematoxylin
and eosin (H&E)-stained images of tissues exposed to conductive hydrogels after
subcutaneous injection into FVB mice (C) one week and (D) two weeks after
implantation. H&E-stained cells can be seen in the hydrogel areas [81].

2.3.13 Distance of electrode from depot
Drug release from drug reservoirs has been studied under a variety of
conditions and generally electrodes are either in direct contact with the reservoir or
electrodes [73]. In transdermal drug delivery and iontophoresis drug delivery, when an
electrode is in direct contact with the skin and electrode, drugs were able to permeate
through skin [34, 37, 62]. This method is one of the most common methods of drug
delivery with electrical stimulation. Increasing the thickness of the drug reservoir can
decrease permeation of the drug, likely due to the length of diffusion path [64, 94].
This issue can be resolved by increasing electric field strength which increases both
drug permeation and diffusion rates.
Most of these delivery systems require implantation of drug reservoir prior to
stimulation. In subcutaneous drug delivery, the reservoir is implanted under the skin
where the electrode and matrix are not in direct contact with one another, and the
electrode is in direct contact with skin during stimulation. As discussed earlier, this
direct contact might cause inflammation and tissue necrosis at the site of electrode
[56]. By carefully selecting the electric field intensity, duration and polarity this issue
could easily be overcome. Figure 2.18 shows an example of subcutaneous drug
delivery process.
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Drug delivery to deep tissue is always challenging. One of the methods that
has been developed to overcome this challenge is the integration of MEMS (MicroElectro-Mechanical Systems) with electro-responsive hydrogels, and fabrication of
these implantable delivery devices for prolonged controlled drug release [29, 50]. In
recent years, there has been a significant amount of effort to deliver drugs to areas
which are not easily accessible, such as the central nervous systems, which has low
access due to limited permeability across the blood brain barrier [39]. The olfactory
region is the only site in the human body that has direct contact to the central nervous
system. Recently, delivering drug to the brain via the olfactory region has been
proposed, where drugs would diffuse through olfactory mucosa and reach the central
nervous system [112].
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Figure 2.18. In vivo on-demand drug release from conductive hydrogels. In vivo
fluorescent images after applying -1.5 V/cm to the implanted conductive hydrogel on
the left side. The right side hydrogel is the control as no electric voltage was applied to
it. The unit of scale of the right side of the mouse image is photons per steradian per
second. (1) Before applying electric field and (2) & (3) after applying voltage for 40
seconds [81].

2.4. Current efforts on multi-drug delivery using electrically responsive materials
Nanoparticles are promising depots for on-demand multi-drug delivery via
electrical stimulation. By encapsulating drugs with different charges within
nanoparticles on-demand release can be achieved by applying an electric field [81].
Luo et al. [113] developed a system consisting of polypyrrole nanoparticles within
polypyrrole film. It incorporated a drug into the polymer as a dopant and integrated
another drug into the nanoholes inside the polymer films. Figure 2.19 demonstrates
on-demand multi drug-release from conductive hydrogel by controlling electric field
polarity. In addition, microchips can be easily programmed for multi-drug release
[48], as shown in Figure 2.20.

A

B
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Figure 2.19. On-demand pulsatile multi-drug release from conductive hydrogel.
(A) Release of fluorescein in PBS following application of -0.5 V and -1.5 V for 10
second every 5 minutes. (B) Release of daunorubicin in PBS following application of

0.5 V for 10 second every 5 minutes [81].

Figure 2.20. On-demand multi-drug release from a single microchip device. The
release rate of calcium ions (∆) sodium fluorescein (●). (Release rate unit is ng/min)
[48].

2.5 Conclusions and future perspectives
Electrically-responsive biomaterials for targeted drug delivery have gained the
interest of scientists in recent years. Applying an electric field to skin and tissue can
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enhance membrane permeability, which can enhance absorption of drug. Moreover,
this application is beneficial for delivering large molecules to tissue that normally
exhibit poor absorption. The aforementioned biomaterials are biocompatible and have
similar mechanical properties with surrounding tissue, which can minimize the foreign
body response. By carefully selecting the hydrogel material and its properties, gels can
be designed that incorporate drug(s) within their network. Additionally, by controlling
morphology of these systems (mesh size and porosity), adding conductive materials,
and controlling the electric field intensity and polarity, a desired quantity of drug
released can be achieved without damaging the surrounding environment.
Additionally, recent studies demonstrate that hydrogel systems can be engineered in a
manner where multiple drugs can be delivered to the tissue.
Wireless technologies have the potential to overcome invasiveness and the risk
of necrosis while enabling on-demand multi-drug delivery. Conductive hydrogels are a
promising technology that have great potential for drug delivery to deep tissue, which
currently poses a great challenge to scientists. Hydrogel matrices can be engineered to
release drugs using a weak electric field density where the electrophysiological
activity of body could generate the required electric field. In addition, devices such as
a pacemaker or pulse generator can be designed and implanted to generate the required
electric field for drug delivery.
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Abstract
Electrically conductive materials with soft, tough, and tunable mechanics have
utility in a wide range of applications including neuroprosthetics. Such materials can
serve as interfaces between electrical components and tissues, providing mechanical
matches with, and better conformations to, soft irregularly shaped surfaces. Hydrogels
can potentially provide these attributes while remaining hydrated for long periods of
time—providing a long-term and stable electronic-tissue interface. Additionally, in
applications that demand implantation, hydrogels can be formulated to locally deliver
enhancing therapeutics. Here, hydrogels are developed by entrapping a conducting
polymer within a crosslinked poly(acrylic acid) (pAAc) network. Critically, these
hydrogels were cast under freezing conditions which produces cryogels that exhibit
macroporous, soft, and highly tunable mechanics (0.2 – 20 kPa, by varying pAAc and
crosslinker concentrations). Additionally, these cryogels are tough enough to survive
over 90% compression, which enables survival after being passed through 16-gauge
needles. Cryogels also exhibit electrical conductivities that were sufficient to record
alpha-waves from the scalp of human subjects. Growth of fibroblasts cultures in the
presence of these cryogels produce statistically similar viabilities compared to controls
and did not disrupt fibroblast cell cycles. Finally, cryogels are capable of being loaded
with and delivering proteins that can combat inflammation.

Keywords: hydrogels, electrodes, conductive polymers, neuroprosthetic
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3.1 Introduction
Electrically conductive materials that exhibit soft, deformable, but tough
mechanical properties are highly desirable in a wide range of applications. For
example, such materials could enhance neurological disorder treatment strategies—a
family of disorders that affect up to a billion people worldwide and are on the rise due
to gradual increases in life expectancies [1]. Neuroprosthetic devices that can restore
functionality or reduce the symptoms exhibited by patients suffering from
neurological diseases often require the use of electrodes to stimulate and/or record
signals from neural tissues [2]. For instance, deep brain stimulation (DBS) uses
implanted electrodes to electrically stimulate targets within the brain [3, 4], which can
reduce symptoms exhibited by patients with Parkinson’s disease, essential tremor,
dystonia, chronic pain, major depression, and obsessive-compulsive disorder [5]. Such
strategies require an electrode-tissue interface whose electrical conductivity remains
sufficiently high to transmit neural signals over time [6]. Metallic electrodes are
typically used as the electrode material in these neuroprosthetic applications due to
their high electrical conductivity. However, the stiffness of metallic electrodes can be
problematic, especially in applications that require prolonged electrode-tissue interface
and/or applications that demand electrode implantation within tissues. Specifically,
stiff electrodes can have difficulty remaining in contact with soft, curvilinear surfaces
(e.g., against the skin in electroencephalography (EEG) and electrocardiography
(ECG) applications). Conductive pastes (such as Ten20 Conductive EEG Paste) are
typically used to as interfaces to help facilitate a stable electrical pathway between
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electrodes and soft surface tissues. However, they involve messy and time-consuming
electrode preparation before use, dry up during use, and are therefore not well-suited
for applications requiring recording/stimulating over prolonged periods of time (e.g.,
for wearable sensors and electronics). For applications that demand in vivo electrode
implantation (e.g., DBS), maintenance of an electrically conductive path across the
electrode-tissue interface is further complicated by the body’s ability to build fibrous
tissue around the implanted electrode, which can greatly reduce interfacial
conductivity [2, 7-9]. Fibrous tissue development at the electrode-tissue interface is
thought to be the result of several factors. First, surgical introduction of a stiff metal
electrode to sensitive tissues can be traumatic and can incite a strong inflammatory
response. As time progresses, the mechanical mismatch between the stiff metallic
electrode and soft tissue can lead to micromotion, shear stresses, continued
inflammation, and a stronger foreign body reaction [2, 8]. These responses can lead to
accelerated fibrous capsule formation around the electrode, thereby accelerating the
loss of the requisite electrically conductive path. Because of the issues outlined above,
this work aimed to develop a versatile material for interfacing between electronics and
tissues that exhibited (i) soft mechanics to help facilitate conformation to curvilinear
surfaces and to provide better mechanical matches with native tissues, (ii) sufficient
electrical conductivity to record low-powered neural signals, (iii) tunable mechanics to
enable application-specific customizations, (iv) toughness and compressibility to
enable less traumatic introduction to tissues via injection, (v) low cytotoxicity, and (vi)
the ability to locally deliver therapeutics that could potentially aid in combatting
inflammation and the foreign body reaction.
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In order to achieve the above-listed properties, a hydrogel-based material was
pursued. Hydrogels are soft materials made from cross-linked hydrophilic polymer
networks [10] and have the potential to locally deliver therapeutic agents such as antiinflammatories [11]. Hydrogels can also have similar mechanical properties as
physiological tissues [12]. However, they normally exhibit poor electrical conductivity
[13] making them inappropriate for use as neuroprosthetic-tissue interface materials
[14-16]. Electrically conductive polymer hydrogels are a unique class of hydrogels
that not only can have similar mechanical properties as neural tissue [17, 18] but can
also have electrical properties similar to metals and inorganic semiconductors.[19] It
has previously been demonstrated that

hydrogels composed

of poly(3-4,

ethylenedioxythiophene) (PEDOT) provide electrical conductivity and stability in
oxidized environments [13, 20-24]. Moreover, PEDOT hydrogels in particular are
biocompatible [25] and can have similar Young’s moduli as neural tissues [2]. For
these reasons, PEDOT was employed as the conductive component of the hydrogelbased interface material described here.
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3.2 Experimental Section

3.2.1 PEDOT/pAAc hydrogel and cryogel preparation:
Different amounts of acrylic acid (AAc), 550 Da Poly (ethylene glycol)
Dimethacrylate (PEGDM), sodium hydroxide (NaOH) (465 µg per ml of AAc),
deionized

water,

(PEDOT:PSS)

and
were

Poly(3,4-ethylenedioxythiophene):polystyrene
mixed

via

vortexing.

Then

sulfonate
N,N,N',N'-

Tetramethylethylenediamine (TEMED) and Ammonium Persulfate (APS) redox
reagents were mixed in to initiate gelation and the solution was immediately
transferred to a 10 x 10 mm cylindrical Teflon mold. This produced non-macroporous
PEDOT/pAAc hydrogels. To produce macroporous cryogels, the same procedure was
followed except pre-gel solutions were transferred to frozen Teflon molds (pre-frozen
at -20 ̊C) and left to gel in a -20 ̊C freezer overnight. Both hydrogels and cryogels
were rinsed in Phosphate Buffered Saline (PBS) for 3 days (exchanging liquid 3 times
daily) prior to running experiments to remove excess reagents and to allow the gels to
fully swell.

3.2.2 Mechanical characterizations:
Gel stiffness (compressive modulus), strain at failure, and toughness were
quantitatively measured in compression using an Instron Model 3345 (Norwood, MA).
Gels of various compositions were placed between the plates of the Instron and
compressed (at 2 mm/min) until failure or reaching 90% strain. Note that 90%
compression was never exceeded as to eliminate the risk of damaging the Instron
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should the plates touch during compression. Recorded stress-strain curves were
analyzed using the Instron’s Bluehill software package to extract moduli, strain at
failures, and toughnesses.

3.2.3 Electrical characterizations:
For measuring IV-curves and direct current (DC) conductivity, gels of various
composition were placed between two stainless-steel plates immediately after swelling
in a hydrated state and excited at 0.5, 1, 2, 4, and 8 VDC. DC current was recorded
and used to generate IV-curves. Additionally, DC conductivity was calculated at
various voltage excitations using these measured currents along with the measured
length and cross-sectional surface area of each fully swollen gel. For measuring
impedance vs. frequency, all gels were cut into 12 mm diameter and 2 mm height
discs after fully swelling. Cut gels of various composition were measured using a GW
Instek LCR-6000 meter (New Taipei, Taiwan) at 2 VAC with 2 VDC bias from 10 Hz
to 100 kHz.

3.2.4 EEG studies:
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels were cast in the 10mm EEG disc electrodes and rinsed/swollen as described above. These PEDOT
electrodes were compared to electrodes integrated with Ten20 paste (Weaver and
Company, Aurora, CO). After cleaning recording locations on the scalp with a mildly
abrasive gel (Nuprep, Weave and Company), PEDOT-, cryoPEDOT, and Ten20integrated electrodes were placed on the back of human subjects’ heads over to the
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occipital lobe and held in place with a sweat band. All recordings were in accordance
with the University of Rhode Island IRB approved protocol. Reference and ground
electrodes were placed on subjects’ foreheads. Each subject had one PEDOT-, one
cryoPEDOT, and one Ten20-integrated electrode in order to record and compare the
same neural signals. Electrodes remained on subjects for 4 hours. EEG signals were
recorded after this 4-hour period with subject eyes being closed and opened using an
EEG amplifier (Grass Comet-Plus EEG/PSG Amplifier system, Grass EEG systems,
Natus Medical Incorporated) and a computer with EEG software (Grass Technologies
EEG Twin 4.5.2).

3.2.5 Gel treatment and injection:
Only 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM gels were used in these
studies. Ethanol-treatment of gels involved submerging fully swollen gels in a 70%
ethanol solution for 1 h. In a biosafety cabinet, ethanol-soaked gels were transferred to
sterilized PBS (sterilized using a 0.22-micron vacuum filter) and rinsed for 3 days in
sterile PBS to remove excess ethanol and to allow the gels to fully reswell (ethanol
treatment did cause some degree of gel collapse). Autoclave-sterilization involved
placing fully swollen gels in 250 mL media bottles containing PBS and loosely
screwing on the media bottle lids. Gel-containing media bottles were treated in a
Tuttanauer 2540 series autoclave (Breda, Netherlands) for 30 minutes at 121°C. After
sterilization, the electrical and mechanical properties of these gels were characterized
and compared to gels that were not sterilized using the mechanical and electrical
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testing methods described above. For injectability, fully swollen gels were cut into 3 x
1.25 mm cylinders and passes through 16-gauge needle with PBS.

3.2.6 Fibroblast culturing:
3T3 mouse fibroblasts were cultured in DMEM with 10% bovine calf serum
and 1% penicillin streptomycin in 75 cm2 flasks at 37°C with 5% CO2. 3T3s were
routinely passaged to maintain confluency under 70% by treating with 0.25% TrypsinEDTA for 10 min, aspirating, centrifugal washing, and re-plating in flaks with fresh
growth media.

3.2.7 Fibroblast studies:
3T3 mouse fibroblasts were cultured and plated on 24-well plates at 1000 cells
per cm and allowed to grow for 24 hours before being exposed to cryogels. 9 wt %
AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm cylinders) were
prepared, rinsed/swollen, ethanol-disinfected (as described above except cryogels
were rinsed in sterilized complete DMEM on the 3rd day of post-ethanol rinsing in lieu
of sterile PBS), and placed directly on top of 2D fibroblast cultures. After 1, 3, and 7
days of cryogel exposure, cryogels were removed and the 3T3s were analyzed by
LIVE/DEAD staining and imaging on a BioTek Cytation 3 plate reader (Winooski,
VT). These images were used to calculate cell viability and live cell count vs. time
using BioTek Gen5 software.

3.2.8 Cell cycle analysis:
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fibroblasts were exposed to PEDOT cryogels as described above, but for 10 full
days rather than 7 (representing 5 to 6 doubling times). After cryogel exposure
fibroblasts were trypsinized, collected, fixed for 15 minutes in ice-cold ethanol, spun
down (400 g for 8 minutes), resuspended in a propidium iodide (PI) staining solution
(Nexcelom Biosciences), and incubated for 40 minutes at 37ºC. Fibroblasts were again
spun down, resuspended in fresh PBS, loaded in to a Nexcelom Cellometer counting
chamber, and analyzed on a Nexcelom Cellometer Vision. The Cellometer Vision
produced PI intensity histograms and enabled the extraction of the percent of cells in
various phases of their cycle, based on relative PI fluorescence intensity, which is
proportional to the relative amount of DNA a cell currently has (which indicates what
stage the cell is in its cell cycle).

3.2.9 Protein release studies:
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm
cylinders) were prepared and rinsed/swollen as described above. Cryogels were gently
blotted using a Kimwipe to slightly dehydrate them. This slight dehydration allowed
for IL-4 to be loaded by adding a concentrated solution of IL-4 (1000 ng and 5000 ng
IL-4 in 100 μL PBS) dropwise to the gel. IL-4-loaded cryogels were left overnight in a
sealed scintillation vial to allow IL-4 to integrate well into the cryogels. These
scintillation vials were previously treated with Sigmacote to prevent binding of
released protein to the walls of the scintillation vial. Cryogels were then submerged in
5 mL of PBS with 1% Bovine Serum Albumen (BSA). Over the course of a month, 5
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mL samples were taken and replaced with fresh 5 mL of PBS with 1% BSA. These
samples were analyzed for IL-4 content using ELISA (R & D Systems).

3.2.10 Sample preparation for SEM imaging:
9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogels (10 x 10 mm
cylinders) were prepared as described in the Experimental section but lyophilized for 3
days instead of being thawed and rinsed. After lyophilization, dehydrated cryogels
were cut in half using a sharp razor to expose the vertical cross-section of the gel. The
cross-cut cryogel was sputter-coated with gold for 30 seconds, mounted, and placed in
the imaging chamber of a Zeiss SIGMA VP Field Emissions Scanning Electron
Microscope (FE-SEM).

3.2.11 Data representation and statistical analyses: All quantitative data presented in
this work are represented as means ± standard deviations. For statistical comparisons
that were limited to single comparisons, a student t-test was applied to calculate
significance with p-values of less than 0.05 being our benchmark for significance. For
instances where multiple comparisons were made across multiple conditions, one-way
Analysis of Variance (ANOVA) with a Tukey’s post hoc test was utilized. The
following convention was used for indicating the level of significance: *, **, ***, and
**** indicate p < 0.05, 0.01, 0.001, and 0.0001 respectively. “n.s.” indicates that this
benchmark for statistical significance was not met (p > 0.05).
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3.3 Results and Discussion
PEDOT hydrogels were generated by entrapping PEDOT polymer within
poly(acrylic acid) (pAAc) matrices using 550 Da poly(ethylene glycol) dimethacrylate
(PEGDM) as a crosslinker (see Experimental Section for more details). A wide variety
of hydrogel formations were created in order to demonstrate tunable mechanics.
However, for each gel formulation it was desired to achieve a high and consistent
electrical conductivity so that mechanical tuning did not overly impact electrical
performance. Therefore, the highest amount of PEDOT was used that could be
integrated into all gel formulations (0.26 wt% PEDOT). Indeed, by altering AAc
monomer and PEGDM crosslinker concentrations (AAc from 4 to 10 wt% and
PEGDM from 1 to 5 wt%), gel stiffness could be tuned over a range of moduli
consistent with tissues (Figure A1). While different gel formulations yielded gels with
different stiffnesses, the DC electrical properties of the gels were similar between gel
formulations when subjected to voltages between 0.5 and 8 V (Figure A2). This
indicates that the amount of acrylic acid and PEGDM crosslinker can be used to
formulate gels with specific levels of stiffness without overly impacting gel electrical
performance. Also, of note was that these gels were relatively tough and compressible,
exhibiting particularly high strain of failures for soft, nanoporous gels (with some
formulations surviving up to 88% compression before failing (Figure A3).
While potentially useful in many applications including neuroprosthetic, these
nanoporous PEDOT/pAAc gels may still present several practical limitations for use
in applications that demand implantation. For example, their introduction to tissues
would require an invasive surgical procedure. Such procedures would be expensive,
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inconvenient, and could inflame the tissue (with downstream effects limiting electrical
conductivity). An alternative approach would be to inject the gel precursor solution
into the tissue and cast the gel in vivo. While the APS/TEMED chemistry used for
gelation here could be inappropriate for this, other more biologically friendly gelation
strategies could be employed. However, even then, an issue with casting a gel within
or against neural tissues is that the gel will swell beyond its original size after injection
(and many of these gel formulations indeed swell greatly beyond their original casting
size, Figure A4). While the degrees of in vitro swelling observed here would likely not
be as severe in vivo (where there is much less water available to facilitate swelling),
even small degrees of swelling could be painful and potentially life-threatening in or
against sensitive neural tissues. An alternative strategy would be to first cast the gels
ex vivo, rinse residual gelation reagents from them, allow them to fully swell, cut them
to desired shapes/sizes, and then inject them into the tissue of interest. An electrical
lead would be introduced to the injected gel (through the void established by the
injection needle) and the injected gel would serve as soft interfacial buffer between the
hard lead and the soft tissue. This injection-based approach would require a
conducting hydrogel with highly compressible mechanics. While the PEDOT gels
presented here exhibited mechanical properties that would suggest a high degree of
compressibility and potential injectability, they were not capable of surviving the
strains associated with injection. For example, after swelling fully, a gel formulation
that exhibited a combination of being soft with high conductivity and high strain of
failure (the 9 wt% AAc, 0.26 wt% PEDOT, 1 wt% PEGDM gel) failed at 80%
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compression (Figure A5a) and did not survive after being passed through a 16-guage
needle (Figure A5b).
In order to generate conductive hydrogel structures that were capable of surviving
the stresses associated with injection after fully swelling, gels were engineered to have
shape-memory properties [26] which can enable minimally invasive injection of
hydrogel materials [27]. Shape-memory properties were achieved by adopting a
cryogelation approach during fabrication [28] where a gel precursor solution was
prepared (Figure 3.1a, i) and frozen during polymerization and crosslinking. Ice
crystal nucleation and growth during freezing forced all gel constituents to the
interstitial space between ice crystals, concentrating the matrix between ice crystals
(Figure 3.1a, ii). After cryogelation, the mixture was thawed, leaving macropores in
the spaces previously occupied by ice crystals (Figure 3.1a, iii). The result of this
process was a three-dimensional structure entrapping PEDOT with a spongy,
macroporous structure (Figure 3.1b). Just as with their room-temperature-cast
counterparts, these PEDOT cryogels were capable of exhibiting a wide range of
stiffness depending on their formulation (Figure 3.1c, i) with high strain of failures
and toughness for soft hydrogels (Figure 3.1c, ii and iii). In fact, several gel
formulations did not fail under 90% compression (Fig. 3.1c, ii and iii: denoted with ‡).
Thus, their actual strain of failure and toughness values could not be measured since
compressions beyond 90% were not attempted (in order to prevent equipment
damage). Accordingly, many of the values presented here represent minimum strain of
failure and toughness values. Elsewhere, similar cryogelation approaches have been
employed to produce gels with interconnected macropores [29], moduli similar to
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biological tissues [30, 31], sufficient mechanical toughness to remain intact when
exposed to cyclic compression (50% compression, 1000 cycles) [32], and the ability to
spring back to form after compression through needles [28]. The novelty here is that
the PEDOT/pAAc cryogels also exhibited electrical attributes potentially useful in
neuroprosthetic.

Figure 3.1. Cryogelation of PEDOT/pAAc hydrogels result in macroporous
structures with soft, tunable, and compressible mechanics. (a) Schematic detailing
the cryogelation process. (b) Photograph (top) and SEM cross-section (bottom) of a 9
wt% AAc, 1 wt% PEGDM, 0.26 wt% PEDOT cryogel. (c) Compressive Young’s
modulus (i), strain of failure (ii), and toughness (iii) vs. acrylic acid concentration for
PEDOT/pAAc cryogels that were crosslinked with 1 wt% (red), 2 wt% (blue), or 5
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wt% PEGDM. *, **, and **** indicate statistically significant differences with pvalues of less than 0.05, 0.01, and 0.0001, respectively (N = 4). ‡ indicates that gels
did not fail when compressed at 90% strain. Thus, strain of failure was at least 90%
and hydrogel toughnesses were underestimates.

In order to explore the use of these hydrogels specifically in neuroprosthetic
applications, PEDOT/pAAc cryogels were electrically characterized. Current vs.
voltage curves (IV-curves) for a wide range of gel formulations showed, as expected,
that conductivity was lower when excited at low voltages (Figure 3.2a, IV-curves had
relatively small slopes at voltages between -2 and +2 V) and higher conductivities
when excited at higher voltages (IV-curves had higher slopes at voltages less than and
greater than -2 and +2 V, respectively). Computed conductivity values for various gel
formulation and at various voltage excitation values can be found in Figure A6. While
lower conductivities were recorded at voltage excitation levels lower than the overpotential at the metal-hydrogel interface, impedance measurements revealed that these
cryogel systems (for gels cut to 2 x 12-mm cylinders after swelling using an LCR
meter set to use a 2-volt signal) exhibited impedance magnitudes of < 200 Ohms
(Figure 3.2b) (for Nyquist plots of these same impedance data, see Figure A7 in
Appendix A). Critically, because altering gel formulation can be used to tune gel
mechanics (Figure 1c, i) without overly impacting gel conductivity (Figure 3.2a and
3.2b), cryogels could be customized to match the mechanics demanded by the
application without sacrificing electrical performance.
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In order to determine if these electrical characteristics were sufficient to record
low-powered neural signals, a specific cryogel formulation that exhibited both
compressible mechanics (low Young’s modulus and high strain-of-failure) and
desirable electrical attributes (electrical conductivity nearing 1 S/cm) was selected for
further study: the 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogel. This
cryogel formulation was cast on disc electrodes (Figure 3.2c, i: top), allowed to fully
swell, and used to record signals emanating from a human subject’s occipital lobe.
These PEDOT cryogel-integrated disc electrodes (Figure 3.2c, i: bottom (blue)) were
compared to electrodes integrated with Ten20 conducting paste (Figure 3.2c, i: second
from top (red)) and a non-cryogelated PEDOT gel (second from bottom (green)).
Compared to a popular EEG conducting paste (Ten20, which was found to be superior
to other EEG conducting pastes on the market) [33]. electrodes with PEDOT cryogels
were able to record neural signals at similar amplitudes and spectral powers (Figure
3.2c, ii & iii: red and blue curves overlapped). When compared to a non-cryogelated
PEDOT hydrogel (a formulation comparable to a PEDOT hydrogel reported elsewhere
[13, 26, 27, 29-32, 34-37]), these cryogels also performed similarly (Figure 3.2c, ii &
iii: green and blue curves overlapped). Specifically, PEDOT cryogels provided similar
degrees of signal and spectral resolution to those of a commercially available
conductive paste and non-cryogel PEDOT gels. This enabled the observation of alpha
waves when the subjects’ eyes were closed (Figure 3.2c, ii, bottom: peak in signal
from 7.5 – 12.5 Hz) and decreased alpha waves when subjects opened their eyes
(Figure 3.2c, ii & iii, bottom: drop in signal power between 7.5 – 12.5 Hz with eyes
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opened (iii) vs. closed (ii)). Additionally, 1-hour exposure to PEDOT cryogels did not
visually impact the skin (Figure A8).

Figure 3.2. PEDOT/pAAc cryogels exhibited conductive electrical properties
sufficient to record neural signals. (a) A schematic (i) and photo (ii) of a 9 wt%
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM cryogel completing an LED circuit. (b) DC
conductivity vs. acrylic acid concentration for PEDOT cryogels crosslinked using 1
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wt% (red), 2 wt% (blue), and 5 wt% (blue) PEGDM. (c) (i) Impedance vs. frequency
for 4 wt% AAc, 0.26 wt% PEDOT cryogels crosslinked with 1 wt% (red) and 5wt%
(blue) PEGDM. (ii) Impedance vs. frequency for 9 wt% AAc, 0.26 wt% PEDOT
cryogels crosslinked with 1 wt% (red) and 5wt% (blue) PEGDM. (d) (i) Images of
disc electrodes with standard Ten20 paste (blue) and a PEDOT cryogel (red). (ii,iii)
Recorded neural signal vs. time (top) and power spectrum (bottom) when subject’s
eyes are closed (ii) and open (iii). Insets: power spectrum from 7.5 to 12.5 Hz,
highlighting alpha wave power. For all parts, n.s. indicates that no statistical
significance was found (p > 0.05) between any groups (N = 4).

In order to examine how well a fully swollen cryogel retained its mechanical
and electrical attributes after either treatment with ethanol (often used prior to
placement on the skin) or autoclaving (for sterilization), 9 wt % AAc, 0.26 wt %
PEDOT, 1 wt % PEGDM cryogels were mechanically and electrically tested before
and after ethanol-treatment and autoclaving. It was discovered that 70% ethanol
treatment did not have a statistical impact on the cryogel’s Young’s modulus (Figure
3.3a, i: red and blue bars are statistically similar), suggesting that the cryogel’s
structure was not overtly altered by the treatment. However, autoclaving these
cryogels was more disruptive and did have an impact on the gel’s mechanical
attributes (Figure 3.3a, comparing green and red bars/curves). While this may be a
limitation for using these gels in vivo, note that they could potentially be produced as
sterilized products in a clean environment with pre-sterilized materials. In terms of
maintaining electrical properties before and after ethanol-treatment and autoclaving,
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DC conductivity was not statistically impacted by either ethanol-treatment or
autoclaving when excited at 0.5 V (Figure 3.3a, ii: no statistically significant
differences between red, blue, and green bars). This held true when excited at higher
voltages as well (Figure A9).
Because these PEDOT cryogels exhibited particularly soft moduli and high
strains of failure (Figure 3.1c) as well as the electrical ability to transmit neural signals
(Figure 3.2c), experiments were conducted to examine if these cryogels could survive
the compressions associated with injection. A cylindrical cryogel was compressed to
90% of its height and was able to eventually spring back to form after compression,
remaining structurally intact (Figure 3.3b). This compressibility allowed these
cryogels to survive being passed through a 16-gauge needle (Figure 3.3c). There have
been other efforts to create injectable conducting hydrogels, though using in situ
gelation to achieve injectability [38-40]. While adopting novel in vivo gelation
strategies, these studies yielded gels that swelled after injection (from 120% to 500%)
which could be highly problematic since swelling could damage sensitive neural
tissues.
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Figure 3.3. A PEDOT/pAAc cryogel can retain its mechanical and electrical
attributes after being treated in ethanol and can survive high degrees of
compression. (a) Young’s modulus (i) DC conductivity when measured with a 0.5 V
signal (ii), and impedance vs. frequency (iii) for 9 wt% AAc, 0.26 wt% PEDOT, 1
wt% PEGDM cryogels before treatment (red) and after ethanol-treatment (blue) or
autoclaving (red). (b) Stress vs. strain for the same cryogel when brought to and from
90% compression. Inset: photographs of the cryogel before and after compression. (c)
Photographs of a 3 x 1.25 mm cylindrical cryogel (as formulated in parts (a) through
(b)) before and after being passed through a 16-guage needle.
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In order to assess the viability of cells in the vicinity of these cryogels, fibroblasts
studies were performed. 3T3 fibroblasts were plated and allowed to establish
themselves for 24 hours. A 9 wt % AAc, 0.26 wt % PEDOT, 1 wt % PEGDM cryogel
was then placed directly on top of the 2D culture while fibroblast viability was
monitored over the subsequent week and compared to controls (Figure 3.4a).
LIVE/DEAD staining was performed (Figure 3.4b) to quantify cell population and
viability over time. These analyses revealed that presence of a PEDOT cryogel did
inhibited fibroblast growth vs time (Figure 3.4c, i: solid curve reaching lower cell
densities than the dashed curve). This may have been the result of cells physically
having less space to grow. In fact, the LIVE/DEAD image of the fibroblasts that grew
for 7 days underneath a PEDOT cryogel reveals spots where cells did not invade
(Figure 3.4b, bottom right fluorescent image). These could be locations where the
cryogel made strong contact with the well-plate, physically limiting cell infiltration.
The presence of a PEDOT cryogel, however, did not statistically impact fibroblast
viability vs. time (Figure 3.4c, ii). Additionally, cell cycle analyses were performed on
fibroblasts after exposure to PEDOT cryogels for 10 days (fibroblast doubling time is
typically 18-24 hours). These studies revealed that PEDOT cryogel exposure did not
statistically impact the progression of fibroblasts through their cell cycles (Figure 3.4c,
iii). Propidium iodide (PI) histograms from these cell cycle analyses are provided in
Supporting Information (Figure A10). The findings here are consistent with other
reports. Elsewhere, PEDOT-based materials have (i) exhibited good biocompatibility
with epithelial cells, neural cells, and fibroblasts [41], (ii) incited minimal
inflammation in vivo [42, 43], and (iii) demonstrated the ability to reduce gliosis
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(glial-scar formation around materials implanted in brain tissue) [44].

However,

further studies are needed to assess PEDOT cryogel biological performance. For
example, viability, proliferation, and cell cycle analyses for other pertinent cells types
(e.g., neurons and glia cells) will need to be performed. Additionally, in vivo studies
will be needed to examine the performance of the specific PEDOT cryogel developed
here, since the inflammatory response (which is not present in vitro) would play a
critical role in implant performance.
Finally, a possible strategy for preserving an electrical pathway at the interface
between neural tissues and electronic components in vivo is to have that interface
locally deliver therapeutics that can help prevent fibrotic tissue formation. We
hypothesized that these hydrogels would be particularly well-suited to locally deliver
these types of therapeutics. To demonstrate this capability, 9 wt % AAc, 0.26 wt %
PEDOT, 1 wt % PEGDM cryogels were loaded with Interleukin-4 (IL-4)—a protein
that can inhibit the inflammatory response of macrophages by differentiating them
towards pro-repair phenotypes [45-47]. Release studies showed that IL-4 release was
initially rapid, reaching ~10 ng of cumulative release within the first 24 hours,
depending on the amount of protein loaded in the gel (Figure 3.4d, blue and red curves
at 1 day). This initial burst release could be of particular use during the acute phase of
inflammation immediately following cryogel introduction to the tissue. PEDOT
cryogels continued to release IL-4 in lesser amounts over the course of the next 30
days (Figure 3.4d, blue and red curves after day 1). Additionally, these data showed
that different amounts of cumulative IL-4 release could be achieved simply by loading
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the gels with different amounts of protein (Figure 3.4d, comparing the values of blue
and red curves vs. time).

Figure 3.4. PEDOT cryogels do not disrupt fibroblast viability and cell cycle and
can deliver proteins that may help reduce inflammation. (a) Schematic of in vitro
viability experiments. (b) Green/red (live/dead) fluorescent images of 3T3 fibroblasts
on days 1 through 7 when cells are not exposed to a gel (top) or exposed to a 9 wt%
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM cryogel. (c) Cell density (i) and viability (ii)
vs. time when cells are not exposed to a gel (dashed curve) or exposed to a the
PEDOT cryogel (solid curve). (iii) Percent of fibroblasts in various stages of their cell
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cycle after 10 days of exposure to PEDOT cryogels (grey) vs. fibroblasts not exposed
to gels (white). ** and *** indicate statically differences between cryogel exposed
cells and controls with p < 0.01 and 0.001, respectively. n.s. indicates that no
statistical differences were found (p > 0.05). N = 4. (d) Cumulative IL-4 release vs.
time for the PEDOT cryogel after being loaded with 1 μg (red) or 5 μg (blue) of IL-4.
N = 4.

Despite not being injectable after fully swelling, the nanoporous PEDOT/pAAc
room-temperature-cast hydrogels (characterized in Figs. A1-A5) exhibited attributes
potentially beneficial in many neuroprosthetic applications. Their combination of soft
but tunable mechanics (Figure A1: 0.5 – 65 kPa), toughness (Figure A3: 30 – 88%
strain of failures, absorbing 1 – 7.5 kJ/m3 before failing), ability to transmit neural
signals (Figure 3.2c, green), and ability to remain hydrated (by virtue of being a
crosslinked network of hydrophilic polymer) could be highly useful in applications
where electrical contact must be maintained between electrical components and soft,
curvilinear skin surfaces (e.g., EEG- and ECG-based applications). Use of these
conductive hydrogels could provide improvements over the conductive pastes
traditionally used for interfacing between electronics and tissues. For example,
conductive hydrogels would involve less messy preparation, could conform better to
irregularly surfaced skin, and could maintain electrical contact for longer periods of
time without drying out.
The macroporous PEDOT/pAAc cryogels developed here (Figures 3.1 – 3.4)
present several unique advantages for use in both topical and implanted
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neuroprosthetics applications. These conductive cryogels were composed of relatively
inexpensive and biocompatible materials and were capable of being formed using
straightforward techniques. Their tunable and soft (0.2 – 22 kPa Young’s moduli) yet
tough (1.5 – 6 kJ/m3) and compressible (50 – >90% strain of failures) mechanical
properties provide specific advantages: (i) better mechanical matches with tissues than
traditional metal electrodes alone and (ii) enable survivable compression through
needles after fully swelling, and the ability to inject in or against sensitive tissues
rather than surgical introduction. These desirable mechanics coincide with electrical
properties that permit the recording of low-power neural signals, performing as well as
conductive pastes that are currently commercially available (Figure 3.2c). Moreover,
when compressed, these PEDOT cryogels’ electrical resistances are significantly
reduced (Figure A11, nearly 10-fold drop in DC resistance at 80% compressive
strain), likely due to shortening of the electrical path. Thus, when pressed in or against
tissues, they are expected to exhibit improved conductivity, enhancing their ability to
record bio-electrical signals.
The mechanical and electrical attributes of the PEDOT/pAAc cryogels produced
here build upon previous successes with formulating electrically conductive
hydrogels. For example, hydrogels previously formed by interpenetrating electrically
conductive polymer (such as polyaniline (PANi) or PEDOT) within crosslinked
polymeric networks resulted in gels with conductivities on the order of 0.001 to 0.034
S/cm and mechanics appropriate for many applications (fracture strains ranging from
60% to 90% and compressive stresses up to 1.1 MPa) [13, 15, 25, 35-38, 48]. One
study [13] demonstrated that conducting PEDOT networks could be formed within
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dual networks (a poly(ethylene glycol) methyl ether methacrylate (PEGMA) network
and a pAAc network), producing tough (surviving 80% compressive strains under ~4
MPa stresses with Young’s moduli ~ 90 kPa) and electrically conductive (~1 S/cm)
gels at close to physiological pHs (pH = 6). Note that these dual network gels’
mechanical and electrical properties could be further enhanced by subjecting them to
acidic environments. While the dual network gels produced by Nacify et al. [13]
provided excellent mechanical and electrical attributes for use as strain sensors, they
likely lacked the highly compressible mechanics needed for post-swollen injection
(i.e., a combination of very low Young’s moduli and high strain of failures). Here, a
simple cryogelation was used to produce conductive hydrogels with interconnected
macroporous structures, thus endowing them with softer and compressible mechanics.
This cryogelation strategy could likely be applied to other conducting hydrogels
networks (such as those discussed above [13, 25, 35-38, 48] ) as a means to reduce
stiffness and improve compressibility.

3.4 Conclusion
In summary, electrically conductive hydrogels with macroporous, soft, and
compressible attributes were produced using a simple cryogelation approach and were
shown to be capable of being passed through 16-guage needles for potential injection.
The mechanical properties of these cryogels were tunable based on formulation, and
alterations in cryogel formulation did not overly impact electrical performance.
Cryogel electrical properties were sufficient to record low-power neural signals. These
conductive cryogels did not impact fibroblast viability or cell cycle over the course of
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7 days but did hinder fibroblast growth and spreading compared to controls. Finally,
these cryogels were capable of being loaded with anti-inflammatory protein (IL-4),
releasing this protein over the course of a month. Taken altogether, these capabilities
could improve interfaces between tissues and electronics in a wide range of
neuroprosthetic applications and in other applications that demand soft but tough and
tunable mechanical properties coupled with the ability to transmit electrical signals.

Supporting Information
Supporting Information is available at appendix A.
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Abstract
Electroencephalography (EEG) is one of the most important noninvasive
methods for studying the brain’s neural activity, and is used broadly in both diagnosis
and research. However, conventional EEG methods do not provide adequate spatial
resolution and signal-to-noise ratios for many emerging diagnostic and research
applications. To address these inadequacies, high-resolution EEG methods are piquing
the interest of researchers and clinicians. One such method, the use of tripolar
concentric ring electrodes (TCREs), utilizes surface Laplacian theory and three
concentrically arranged electrodes per sensor to address these issues. Although TCREs
have been shown to significantly improve the spatial resolution and signal-to-noise of
EEG signals it, like other electrode-to-scalp techniques, requires using conductive
paste at the electrode-scalp interface. This not only electrically partially short-circuits
the three concentric channels of the TCRE but also the paste can dry out over time.
These issues prohibit TCREs from providing their true potential in terms of EEG
spatial resolution and signal-to-noise ratio, especially in applications that require EEG
recordings for prolonged periods of time. To address these issues, TCREs with
electrically conductive hydrogels were developed to (i) eliminate the need for
conductive paste, (ii) provide improved isolation between channels, and (iii) improve
signal-to-noise ratio preservation over time. The aim of this work was to develop
conductive hydrogels, integrate them into TCRE configurations, and characterize their
sustained electrical properties over time as compared to TCREs with conductive paste.
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4.1. Introduction
Electroencephalography (EEG) is a technique used to measure electrical
impulses generated by brain activity and is relatively affordable and easy to
implement. The EEG provides excellent temporal resolution of complex brain signals
which makes it ideal for diagnosing certain neurological diseases. For example, EEG
is used to diagnose epilepsy, dementia, Alzheimer’s disease [1], psychosis such as
depression and schizophrenia [2, 3], and narcolepsy [4]. In addition EEG can be used
to evaluate the overall brain electrical activity of patients suffering from brain trauma
[5, 6], extent of brain damage in comatose patients [7], drug intoxication, and
encephalopathy [8]. Furthermore, EEG is extensively used in rehabilitation
applications such as in brain-computer interfaces to provide control of prosthetic
movement in patients with paralysis [9-12]. However, while EEG’s excellent temporal
resolution makes it highly desirable, EEG does not inherently provide good spatial
resolution. This limits the use of EEG in emerging research and clinical theaters where
excellent spatial and temporal resolutions are needed to monitor the spatiotemporally
complex activities of the brain (e.g., real-time mapping/imaging of brain activity). If
EEG techniques can be endowed with better spatial resolution, it will prove to be a
powerful tool in a wide range of emerging and future neurological diagnostics and
treatments.
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Because of this potential, there are several methods designed to improve the
spatial resolution of EEG. Some of these methods, based on surface Laplacian theory,
do not require predetermined modeling of the head’s conductive heterogeneity, but
nonetheless provide similar results as other methods that do require this predetermined
modeling (e.g., cortical imaging) [13]. Surface Laplacian methods enhance spatial
selectivity and source identification, attenuate universal noise, and improve signal-tonoise ratio. Moreover, surface Laplacian methods are independent of reference
electrode location and even improve temporal resolutions [11, 14-17]. These attributes
make these methods superb choices for high resolution EEG. There are many versions
of surface Laplacian theory to process brain activity and different types of EEG
electrode designs based on surface Laplacian theories. Most of these electrodes have a
center conducting disc and one or more ring electrodes around the center disc; for
example, a bipolar electrode, tripolar concentric ring electrode, and concentric ring
electrodes (with one center disc and several rings around it). Increasing the number of
rings around the center disc can enhance spatial selectivity even more, but
improvements in spatial selectivity become negligible at some point. Studies have
shown that electrodes with a center disc and two or three rings are the optimal [18, 19]
(e.g., a center disc with two rings around it: a tripolar concentric ring electrode or
TCRE, which will be investigated here) (Figure 4.1A).
Like traditional disc-shaped EEG electrodes, TCRE (and other multi-channel
electrodes designed based on surface Laplacian theory) require electrical contact with
the patient’s scalp. To improve the electrical connection between an electrode and the
patient’s skin, a conductive paste is typically used [20]. While this paste significantly
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improves the electrode-skin interface connection, it also partially electrically shorts
out the channels of TCRE configuration, somewhat limiting its ability to provide
enhanced spatial selectivity (Figure 4.1B Right). To make matters worse, conductive
pastes dry out over time, affecting signal quality and increasing noise over time. This
limits their use in applications that involve EEG spatiotemporal analysis over
prolonged periods of time (e.g., in wearable electronics). Thus, technologies that can
provide prolonged conductive interfaces between TRCEs and a patient's scalp without
shorting out the channels could enable a wide range of EEG-based therapies and
diagnostics.

A

B
Ch.1 Ch.2
Ch. 1. (outer ring)
Ch. 2. (middle ring)
Ch. 3. (center disk)

Ch.1 Ch.2

Ch.3

Ch.3
TCRE

TCRE
air

scalp

C

Ch.1 Ch.2

Ch.3

Traditional conducting paste
scalp

TCRE
alginate

PEDOT
hydrogel

scalp

PEDOT

AAD

pore

Alginate-PEDOT schematic

Figure 4.1. Conductive hydrogel not only provides contact between electrode and
skin but also improves isolation between channels. Comparison of electrode’s
contact with skin with different conductive interfaces. (A) Tripolar concentric ring
electrode (TCRE). (B) Left, TCRE in contact with skin without any interface, Right,
TCRE with conductive paste (TEN20 paste) in contact with skin. (C) Tripolar
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concentric ring hydrogel electrode (TCRHE) in contact with skin on left and
schematic of conductive hydrogel on right.
Hydrogels are soft materials which are made from cross-linked hydrophilic
polymer networks [21]. Although they are insoluble in water, they can preserve a large
fraction of water within their network for prolonged periods of time and retain 3D
shapes, unlike conductive pastes [22]. However, hydrogels typically exhibit poor
conductivity [23]. Although this is not an issue in many applications, for use as an
interface between electrodes and skin, conductivity is a critical priority [24, 25].
Conductive polymer hydrogels are a unique class of hydrogels which not only have
soft mechanical properties similar to skin [26], but also have electrical properties like
metals and inorganic semiconductors [27]. There are several conductive polymers
available which are widely used for fabricating conductive hydrogels, though for use
as electrodes in neural interfaces: polypyrrole and poly(3-4, ethylenedioxythiophene)
(PEDOT) are primarily used [28]. It has recently been demonstrated that PEDOT
provides improved conductivity and stability in oxidized environments over
polypyrrole [22, 24, 29-32]. Moreover, PEDOT is biocompatible [33]. Thus, PEDOT
will be employed as the conductive component of the hydrogel electrodes.
While PEDOT hydrogels have been created previously, they have yet to be
employed as a means to enhance spatial resolution of multi-electrode systems by
providing soft, 3D conducting structures that retain their shape and moisture over
prolonged periods of time. Thus, the work proposed here is a novel step forward in the
context of contemporary technologies. The hypothesis guiding this work is that
electrodes can be made from conductive hydrogels which can be formed in any
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desirable shape (i.e., a TCRE configuration) and retain that shape, thus providing
improved isolation between TCRE channels and prolonged conductivity and contact
with scalp (Figure 4.1C). Specifically, this study involves the synthesis of conductive
hydrogels with multiple polymers and crosslinkers and evaluation of their structural,
mechanical and electrical behaviors to identify an optimal hydrogel formulation to
integrate into TCRE configuration and refine electrode design to optimize its
performance and improve channel isolation. Moreover, we performed EEG testing to
compare hydrogel-integrated TCRE (TCRHE) to regular TCRE with conductive paste.

4.2. Materials and Methods

4.2.1 Materials
For

alginate-PEDOT

(alg-PEDOT)

hydrogels,

alginate

(PROTANAL

LFR5/60) was purchased from FMC. Adipic acid dihydrazide (AAD), 1hydroxybenzotriazole
ethylcarbodiimide

hydrate
hydrochloride

(HOBt),
(EDC),

N-(3-dimethylaminopropyl)-N’poly(3,4-ethylenedioxythiophene)-

poly(styrene sulfonate) (PEDOT:PSS) and phosphate buffered saline (PBS) were
purchased from Sigma-Aldrich (St. Louis, MS). Sigmacote for coating glass sheets
was purchased from Sigma-Aldrich (St. Louis, MS). All materials were used without
any modification.
For polyacrylic acid-PEDOT (PAAc-PEDOT) hydrogels, acrylic acid (AAc),
sodium hydroxide (NaOH), poly(ethylene glycol) dimethacrylate (PEGDM), poly(3,4ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS or PEDOT from now
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on), N,N,N',N'-Tetramethylethylenediamine (TEMED), ammonium persulfate (APS),
aluminum oxide column, and phosphate buffered saline (PBS) were purchased from
Sigma Aldrich. All materials were used without any modification, except AAc, which
was purified using aluminum oxide column to remove the inhibitor.
To fabricate the tripolar concentric ring hydrogel electrode (TCRHE), a
tripolar concentric ring electrodes (TCREs) were acquired from CREmedical. The
tripolar concentric ring mold (TCR mold) was printed using a 3D printer. Epoxy
(marine epoxy) and sealant were purchased from Amazon and the conductive hydrogel
was fabricated in a manner described in detail in the next sections.

4.2.2 Hydrogel synthesis
For preparation of alg-PEDOT hydrogels, alg-AAD solution was prepared
first, where different amounts of alginate (2 – 5 wt %) were added to deionized water
(DI water) and stirred until fully dissolved. The AAD (2.5 and 5 mM) and HOBt were
added to the mixture until fully dissolved, and the resulting solutions were stored at
4C. 2 ml of alg-AAD solution was mixed with 2.5 ml of PEDOT, 0.5 ml of EDC (50
mg/ml) was added, and immediately after mixing the mixture was poured onto a
Sigmacoted glass sheet. Another piece of Sigmacoted glass sheet was placed on top of
the solution with 2 mm spacing, and after 30 minutes hydrogels were cut with a biopsy
punch and stored in PBS.
To make pAAc-PEDOT hydrogels, different amounts of purified AAc (4 -10
wt %), PEGDM solution (1, 2 and 5 wt %), NaOH solution (465 µl per ml of AAc),
PEDOT (0.26 wt %) and DI water (depending on hydrogel formulation DI water may
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or may not be added) were added and vortexed. TEMED and APS (137 mg/ml) were
then added to the solution to initiate gelation. This solution was immediately
transferred to 10x10 mm cylindrical Teflon molds and left to gel at room temperature
for three hours. Samples were then removed and stored in PBS.

4.2.3 Degree of swelling
To measure degree of swelling, the height and diameters of the hydrogels were
measure before immersion into PBS to evaluate their volume (Vbefore). After samples
were fully swollen and had reached equilibrium their height and diameters were
measured again (Vafter), and degree of swelling was calculated from:

degree of swelling =

Eq. 4.1

4.2.4 Mechanical characterization
The Young’s modulus, strain of failure (SoF) and toughness of the hydrogels
were quantitively measured using a compression testing. For mechanical
characterization, the sample was placed between grids of an Instron Universal Testing
System (Model 3345) and compressed until failure. After the compression test on a
given sample, a stress-strain curve was obtained, and mechanical properties such as
Young’s modulus, strain of failure and toughness were obtained from this curve.

4.2.5 Electrical characterization
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Prior to measuring the electrical properties of the hydrogels, fully swollen
samples were cut into discs 12

0.1 mm in diameter and 2

0.1 mm in height. A

sample was then placed between electrodes and -8, -2, -1.5, 1.5, 2 and 8 Volts (Electro
industries DIGI 360) were applied, and the current (Fluke 115) was measured. For
measuring impedance (LCR-6300), hydrogels were exposed to different frequencies
(10, 50, 60, 100, 120, 1000, 2000, 10000, 20000, 40000, 50000 and 100000 Hz at 10
mv) and the magnitude of impedance and phase angle were recorded.

4.2.6 Hydrogel electrode fabrication
Molds with ring sizes and heights similar to those of the TCRE were printed
using a 3D printer (Original Prusa i3 MK2). Figure 4.2A show the TCRE, and Figure
4.2B illustrates the mold design. Sealant was applied on the edge of the electrode wall
between the rings (Figures 4.2C (i) and 4.2D (i)) to improve insulation between the
rings. A traditional TCRE (prepared ahead of time) was inserted inside the mold and
the electrode back was covered with epoxy. Hydrogels were prepared as described
previously, and were injected into the mold, where Figures 4.2C (iv) and 4.2D (iv)
show the prepared TCRHE.
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Figure 4.2. Fabrication of tripolar concentric ring hydrogel electrode (TCRHE).
(A) Tripolar concentric ring electrode (TCRE). (B) TCR mold holds both the TCRE
and conductive hydrogel. (i) TCR mold oblique view. (ii) TCR mold side view, (iii)
TCR mold top view. (C) Schematic of fabricating TCRHE step-by-step. (i) Applying
sealant on the edge of wall between rings to isolate channels and inserting TCRE. (ii)
TCRE is inserted into mold and mold is ready for injection of hydrogel. (iii) Hydrogel
is being injected with 22 gauge needle. (iv) TCRHE. (D) Fabrication of TCRHE step
by step. (i) Sealant is applied on the edge of walls between rings to isolate channels
and inserting TCRE. (ii) TCR mold is ready for injection of hydrogel. (iii) hydrogel is
being injected with 22 gauge needle into TCR mold. (iv) TCRHE. Hydrogel mixture
shown here is 2 w % alginate, 2.5 mM AAD and 0.26 wt % PEDOT.
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4.2.7 Insulation between rings
To measure the insulation between the channels, impedance between the
channels was measured using an LCR meter. Wires attached to each ring were
connected to the impedance meter, and impedance was measured at 10, 50, 60, 100,
120 and 1000 Hz with a 10 mv excitation voltage in ideal conditions, where TCRHE
and TCRE with Ten20 paste were exposed to air.

4.2.8 Electroencephalography (EEG) testing
EEG test was performed on four volunteers, two male and two females. All
volunteers signed IRB consent form. A typical EEG test setup was used. Briefly,
ground and reference electrodes (gold disc electrodes with Ten20 paste) were put on
the forehead of a patient, and TCRHEs and TCRE were placed on the occipital lobe
using a headband. A TCRE with Ten20 paste (as the conductive interface) was in the
center (Oz) and TCRHEs were on the left (O1) and right (O2) occipital lobes. The
electrode attachment sites were swiped with Nuprep prior to testing. The volunteer
was asked to alternately open and close their eyes for about 60 seconds periods. The
tEEG and TCRHE signals were pre-amplified (187.5 V/V) with a t-Interface 20 2.0
(CREmedical Corp.), then amplified (1000 V/V) and digitized (200 S/s) with a Grass
Comet Plus (Grass technologies West Warwick RI) by notch filtering with range of 170 Hz while recording. I assume you used a tInterface.

4.2.9 EEG longevity testing
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A volunteer was asked to wear electrodes for 4h and EEG testing was
performed using the method previously described. The volunteer moved around freely
while wearing the electrodes.

4.2.11 Signal-to-noise ratio
The noise was estimated by obtaining the power spectrum between blinks (1 s)
and the signal-to-noise ratio was derived by dividing the power spectrum for the
condition with eyes closed by the noise.

4.2.12 Statistical analysis
All experiments were performed at least four times. The results were reported
as mean

standard deviation. MATLAB was used to evaluate FFT on EEG results to

acquire the power spectra and signal-to-noise ratios. Statistical analysis was performed
using ANOVA (analysis of variance) with Tukey’s HSD (honestly significant
difference) test at a significance level of 0.05. * indicates p-values < 0.05, ** indicates
p-values < 0.01, *** indicates p-values < 0.001 and **** indicates p-values < 0.0001.

4.3. Results and discussion

4.3.1 Hydrogel synthesis and degree of swelling
To successfully fabricate a tripolar concentric ring hydrogel electrode, a
conductive hydrogel formulation that can remain intact inside the mold should first be
identified. To meet this criterion, PAAc-PEDOT hydrogels and alg-PEDOT hydrogels
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with different polymer and cross-linker concentrations were fabricated. The
conductive polymer (PEDOT) concentration remained constant (0.26 wt %) for all
hydrogel formulations. 0.26 wt % PEDOT was the maximum concentration needed
since initial experiments showed that using higher concentrations of PEDOT did not
improve gel conductivity (data not shown). As shown in Figure 4.3, hydrogel volumes
were measures before and after being fully swollen in PBS to measure and compare
the degree of swelling, which was between 3 – 12 for PAAc-PEDOT hydrogels
(Figure 3A(iii)). PAAc-PEDOT hydrogels were injected into a TCR configuration,
and as expected, they swelled significantly and did not remain inside the mold. Figures
4.3A (i) and 4.3A (ii) show two different PAAc formulations with the lowest and
highest degrees of swelling, respectively.
On the other hand, the degree of swelling remained around 1 for the algPEDOT formulations (Figure 4.3B (ii)), indicating that the degree of swelling for algPEDOT hydrogels was independent of their formulation parameters. Alg-PEDOT
hydrogel formulations were also injected into a TCR mold, and remained in the mold,
proving that alg-PEDOT hydrogels had a degree of swelling around 1 (Figure 4.3B
(i)). The significant differences in the swelling behavior of PAAc-PEDOT and algPEDOT hydrogels are due to the differences in the polymer chains of alginate and
polyacrylic acid. In the hydrogel formulations, sodium ions are present to make crosslinking possible. When the hydrogel swells in PBS, there is a pH difference between
hydrogel network and surrounding medium, and water moves into the hydrogel matrix
until it reaches equilibrium. There are more sodium ions within the PAAc hydrogel
network than the alginate hydrogel network, which causes PAAc hydrogels to swell
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more than alginate hydrogels. Figure 4.3 A(iii) demonstrates that by increasing the
amount of polymer present in the formulation that the degree of swelling increases,
since with increasing polymer concentration, sodium ion concentration increases for
both alginate and PAAc. However, there is a higher concentration of sodium oxide
within PAAc-PEDOT hydrogel formulations in comparison to alg-PEDOT hydrogels.
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Figure 4.3. Alg-PEDOT hydrogel exhibit comparably little swelling. Comparison
of the degree of swelling for different conductive hydrogels with different polymers
including (A) P(AAc) and (B) alginate as the backbone. (A) Integration of P(AAc)PEDOT hydrogel into TCR format for (i) hydrogel with 4 wt % P(AAc), 5 wt %
PEGDM and 0.26 wt % PEDOT (lowest degree of swelling). (ii) Hydrogel with 9 wt
% P(AAc),1 wt % PEGDM and 0.26 wt % PEDOT. (iii) Comparison of degree
swelling for a wide range of P(AAc) (4 - 10 wt %) and PEGDM (1, 2 and 5 wt%) with
constant 0.26 wt % PEDOT. (B) Hydrogel made from different concentration of
alginate and AAD have a swelling degree around 1. (i) Alginate-PEDOT hydrogel
integrated into TCR format for hydrogel with 2 wt % alginate, 2.5 mM and 0.26 wt%
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PEDOT. (ii) Comparison of degree of swelling for a wide range of alginate (2 - 5 wt
%) and AAD (2.5 & 5 mM) with constant 0.26 wt % PEDOT. N = 4 for all parts.

4.3.2 Mechanical properties
For diagnostic purposes, patients frequently are asked to wear electrodes for up
to 24 hours [34]. To make testing more bearable for patients, especially children, we
aimed to use conductive hydrogels that have similar mechanical properties to skin, and
at the same time ones that exhibit favorable toughness to ensure long-term integrity of
the electrodes. To do so, the mechanical properties of the hydrogels, namely Young’s
modulus, strain of failure and toughness were measured (Figure 4.4). Figure 4.4A
shows the mechanical properties of alg-PEDOT hydrogel formulations. The Young’s
modulus was between 2 – 16 kPa for these formulations, and these data indicated that
with increasing polymer and crosslinking concentrations, the Young’s modulus
increases. The alg-PEDOT formulations had Young’s modulus values similar to skin
(Young’s modulus between 50 – 150 kPa [35]). Furthermore, these hydrogel
formulations demonstrated toughness between 2 – 25 kJ/m3 (Figure 4.4B), where the
toughness increased with increasing alginate and cross-linker concentrations. The
hydrogel formulations can withstand high strains (75 % - 83 %) (Figure 4.4C) and algPEDOT hydrogels with 2 wt % alginate/2.5 mM AAD/0.26 wt % PEDOT had a
significantly higher strain of failure in comparison to other formulations. Toughness
and strain of failure are important properties to ensure the long-term robustness, and
consequently, the integrity of electrodes.
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There have been reports of fabricating conductive hydrogels with PEDOT [36]
and 3-4, ethylenedioxythiophene (EDOT) monomer (monomer form of PEDOT) [22].
In these studies, other synthesis methods were used to fabricate a double network
conductive hydrogel which resulted in high Young's modulus and toughness.
Critically, in our study, we demonstrated the ability to explicitly tune hydrogel
mechanical properties by varying the polymer and cross-linker concentrations.
Moreover, the method of conductive hydrogel synthesis described here enables a
relatively fast and straightforward gel fabrication method, and can be adapted for a
variety of polymers to achieve desirable mechanical properties.
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Figure 4.4. Hydrogel mechanics are tunable while degree of swelling remains
around 1. Different hydrogel formulations made from alginate (2- 5 wt%) and
crosslinked with AAD (2.5 & 5 mM) with constant 0.26 wt% PEDOT. Mechanical
characteristics of hydrogels including (A) Young's modulus, (B) toughness, and (C)
strain of failure. N = 4 for all studies.

4.3.3 Electrical properties
Hydrogel electrical properties are independent of their formulation as shown in
Figure 4.5. Figure 4.5A shows the IV curves for alg-PEDOT formulations with
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different alginate and crosslinker concentrations at different voltages. At each
measured voltage, there were no statistically significant difference in the current read
from hydrogel formulation. Also, the impedance of the hydrogels was measured at
different frequencies at 10 mv, and the impedance of the hydrogels decreased with
increasing frequency for all gel formulations. These data confirmed that there was no
statistically significant difference in impedance of the hydrogel formulations at each
frequency (Figure 4.5B). Moreover, the conductivity of these hydrogels was evaluated
at 1.5 v, 2 v and 8v to have a better understanding of their behavior at given voltages
(Figure 4.5C), where the conductivity of hydrogels increased with increasing voltage.
The highest conductivity (about 1 S/cm) was achieved at

8 v.

The conductivity of the hydrogels at any given voltage is controlled by
overpotential. The independence of electrical properties from the formulations was
expected since the same amount of PEDOT (0.26 wt %) was used for all formulations.
Furthermore, our early tests showed that the electrical properties of the hydrogels did
not change with changing PEDOT formulation (data not shown). Independence of
electrical behavior from the formulation is beneficial as it allows for the hydrogel
properties to be tuned depending on the application requirements. A variety of
conductive hydrogel formulations with different amounts of polymer and conductive
polymer components have been designed, resulting in systems with different
properties. For example, depending on the synthesis method and PEDOT/EDOT
concentrations, conductivities between 6.8 x 10-4 to 1 S/cm have been reported for
conductive hydrogels [22, 33, 37-40]. Zhao et al. [36] reported conductivities greater
than 3.3 S/cm for conductive hydrogels comprised of both PEDOT and polypyrrole
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(PPy) conductive polymers. The electrical conductivities reported here and in the
described studies [22, 33, 37-40] are likely appropriate for electrical stimulation and
sensing of neural tissue. For instance, the conductivities of scalp, skull and brain tissue
are 0.33 x 10-3, 0.0042 x 10-3 and 0.33 x 10-3 S/cm, respectively [41, 42]. Overall,
electrode materials should exhibit high conductivities for proper sensing and
stimulation, and the hydrogels designed in this study provide electrical conductivities
well above the described tissues. Furthermore, since the hydrogel formulations
exhibited similar electrical properties, alg-PEDOT hydrogels with 2 wt % alginate, 2.5
mM AAD and 0.26 wt % PEDOT were chosen for fabricating TCRHE since they had
the highest strain of failure.
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Figure 4.5. Hydrogel electrical properties are independent of hydrogel
formulation. (A). IV curve for different hydrogel formulations made from alginate (25 wt%) and crosslinked with AAD (2.5 & 5 mM) with constant 0.26 wt% PEDOT. 8,
4, 2, 1.5, -1.5, -2, -4 and 8 v voltages were applied, and currents were read. (B).
Impedance for different hydrogel formulations made from alginate (2- 5 wt%) and
crosslinked with AAD (2.5 & 5 mM) with constant 0.26 wt% PEDOT. Frequency was
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applied from 10 to 105 Hz at 10 mv voltage. (C) Conductivities for different hydrogel
formulations made from alginate (2-5 wt %) and crosslinked with AAD (2.5 & 5 wt
%) with constant 0.26 wt % PEDOT at (i) V = 1.5 v, (ii) V = 2 v, and (iv) V = 8 v. For
all studies N = 4 and n.s. indicates that no statistically significant difference was found
(p > 0.05).

4.3.4 Isolation between TRE rings
One of the main issues with TCREs is the use of conductive paste, which is
applied between the scalp and electrodes that partially shorts the electrode channels
and affects the quality of signals. Additionally, conductive paste dries over time which
affects the long-term stability of the system. To ensure isolation between the channels
present in the TCRHE, impedance between the channels was measured. Furthermore,
TCRHE with two heights (2.5 and 5 mm) were fabricated to optimize the design of the
system (Figures 4.6 B1). Impedance between two channels was measured at a time.
Figures 4.6A, 4.6B and 4.6C demonstrated impedance between the middle ring to
center disc, center disc to outer ring and middle ring to outer ring for TCRHE,
indicating that the impedance between the channels were at least two orders of
magnitude higher for these systems than TCRE with conductive paste. Higher
impedance between channels is an indication of isolation between the rings (Figures
4.6 and B1).
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Figure 4.6. TCRHE exhibit much better isolation between channels in
comparison to conductive paste, where high impedance between channels
indicates isolation. (A) Isolation between middle ring to center disc. Red for TCRE
with Ten20 paste and blue for 2.5 mm TCR hydrogel electrode (2.5 mm TCRHE) (2
wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). (B) Isolation between center
disc to outer ring. Red for TCRE with Ten20 paste and blue for 2.5 mm TCR hydrogel
electrode (2.5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT).
(C) Isolation between outer ring to middle ring. Red for TCRE with Ten20 paste and
blue for 2.5 mm TCR hydrogel electrode (2.5 mm TCRHE)) (2 wt % alginate, 2.5 mM
AAD and 0.26 wt % PEDOT). Frequency was applied from 10 to 1000 Hz at 10 mv
voltage.

4.3.5 EEG testing
Volunteers (two male and two female) were involved in the study and signed
IRB approved consent forms. To evaluate the performance of TCRHEs and in
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comparison, to TCREs, EEG testing was performed while volunteers wore the
aforementioned electrodes. Figures 4.8 and B3 demonstrated that TCRHE exhibited
better performance compared to TCRE with Ten20 paste, providing higher potential
and power spectrum, especially while patient eyes were closed. Figures 4.7A and S3A
show real-time recording and alpha rhythms, where the alpha rhythm is normal brain
activity when conscious and relaxed, consisting of oscillations of 8 – 13 Hz. Such
rhythms can be detected from the occipital lobe while eyes are closed, and was clearly
observed for all of the electrodes evaluated (2.5 and 5 mm TCRHE and TCRE with
Ten20 paste). Results showed that 2.5 mm TCRHE exhibited higher amplitude in
comparison to TCRE with Ten20 paste. Figures 4.7B and B2B show the power spectra
of the electrodes while patients' eyes were closed, and the inset data showing the
power spectrum for alpha waves clearly indicate that 2.5 mm TCRHE exhibited better
performance in comparison to TCRE with Ten20 paste. Figures 4.7C and B3C show
real-time EEG recordings, where alpha rhythms disappeared as soon as the eyes were
opened. Figures 4.7D and B2D show the power spectra of TCRE and TCRHE while
the volunteer's eyes were open. The data showed that TCRHE can not only record
neural activity, but also have better performance than TCRE with Ten20 paste.
Moreover, Figure B2 shows that 2.5 mm TCRHE exhibited better performance
than 5 mm TCRHE. Since impedance decreases with decreasing thickness, 2.5 mm
TCRHE outperformed 5 mm TCRHE as it had lower impedance. In addition, the 2.5
mm TCHRE had a higher signal-to-noise ratio than the 5 mm TCRHE and TCRE with
Ten20 paste at its peak. The increase in performance of the 2.5 mm TCRHE in
comparison to the 5 mm TCRHE is caused by the differences in their impedance. It
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was also shown that by decreasing the electrode lead height, the signal-to-noise ratio
could be further enhanced (Table 4.1). Since the 2.5 mm TCRHE exhibited better
performance parameters and had higher signal-to-noise ratio than the 5 mm TCRHE
the EEG longevity test was only performed using 2.5 mm TCRHE.
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Figure 4.7. TCRHE have higher amplitude and significantly improves the power
spectrum in comparison to TCRE with Ten20 paste. (A) EEG recording from
occipital lobe using Ten20 paste (red) compared to hydrogel (2.5 mm lead electrode
(blue)) while subject eyes were closed. Inset: zoom-in EEG recording while eyes were
closed. (B) Power spectrum from occipital lobe using Ten20 paste (red) compared to
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hydrogel (2.5 mm electrode lead (blue)) while subject eyes were closed. Inset: zoomin power spectra, highlighting the recording of alpha waves (8-13 Hz) only with eyes
closed. (C) EEG recording from occipital lobe using Ten20 paste (red) compared to
hydrogel (2.5 mm lead electrode (blue)) while subject eyes were opened. Alpha wave
vanished as soon as eyes were opened. (D) Power spectrum from occipital lobe using
Ten20 paste (red) compared to hydrogel (2.5 mm lead electrode (blue)) while the
subject’s eyes were open. Alpha waves disappeared as soon as eyes were opened. For
all parts, N = 4 at 0 hour. * indicates p-values < 0.05.

4.3.6 EEG longevity test
To characterize the durability of the electrodes, EEG testing was performed
after the subject wore electrodes for 4 hours continuously, while moving around
freely. As seen in Figure 4.8, alpha waves were detected and the TCRHE had a higher
signal amplitude compared to TCRE with Ten20 paste. Figure 4.8B shows the,
displayed power spectra while the subject’s eyes were closed, and the inset illustrates
the alpha wave power spectra, indicating that TCRHE had higher power than TCRE
with Ten20 paste after 4h. Figure 4.8D (power spectrum) show data where the
subject’s eyes were open, which showed that TCRHE had a better performance than
TCRE.
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Figure 4.8. TCRHE have higher amplitude and significantly improve the power
spectrum comparing to TCRE with Ten20 paste. (A) EEG recording from occipital
lobe using Ten20 paste (red) compared to hydrogel 2.5 mm lead electrode (blue) while
subject eyes were closed. Inset: zoom-in EEG recording while eyes were closed. (B)
Power spectrum from occipital lobe using Ten20 paste (red) compared to hydrogel 2.5
mm electrode lead (blue) while subject eyes were closed. Inset: zoom-in power
spectra, highlighting the recording of alpha waves (8-13 Hz) only with eyes closed.
(C) EEG recording from occipital lobe using Ten20 paste (red) compared to hydrogel
2.5 mm lead electrode (blue), while subject eyes were opened. Alpha waves
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disappeared as soon as eyes opened. (D) Power spectrum from occipital lobe using
Ten20 paste (red) compared to hydrogel 2.5 mm lead electrode (blue) while subject
eyes were open. Alfa waves disappeared as soon as eyes opened. For all parts, N = 4 at
4 hours. * indicates p-values < 0.05, ** indicates p-values < 0.01.

Table 4.1. Signal-to-noise ratio of electrodes at 0h and 4h for alpha wave (8 – 13
Hz). Signal-to-noise ratio for alpha oscillation for TCRE with Ten20 paste and 2.5
mm TCRHE at 0 hour and 4 hour and for 5 mm TCRHE at 0h.
freque
ncy

Ten20 paste

2.5 mm TCRHE

5 mm TCRHE

(Hz)
0h

4h

0h

4h

0h

4h

8

0.66  0.11

1.26  0.85

0.87  0.17

1.81  0.79

1.03  0.28

-

9

0.96  0.37

1.15  0.54

1.25  0.2

1.46  0.55

1.07  0.27

-

10

3.22  4.01

2.53  0.54

5.61  1.23

2.72  0.98

2.10  0.51

-

11

19.38  2.38

11.65  3.57

21.16  1.77

11.44  2.35

11.69  2.95

-

12

21.46  2.38

14.48  2.68

22.96  8.13

11.15  1.46

14.27  5.62

-

13

6.20  1.65

5.06  0.66

5.61  1.90

4.61  1.04

4.64  3.21

-

Figure 4.9 shows the performance of TCRHE and TCRE with Ten20 paste
over time at 8 - 13 Hz while eyes were closed (alpha waves). The conductive hydrogel
and electrode design enhanced signal amplitude and maintained a steady interface
between skin and the electrode. There was no statistically significant difference in
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TCRHE power after 4 hours, whereas the power decreased over time for TCRE with
Ten20 paste.
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Figure 4.9. TCRHE had higher power spectrum compared to TCRE with Ten20
paste over time. 8 - 13 Hz (alpha waves) while subject’s eyes were closed. N = 4 for
all parts. * indicates p-values < 0.05, ** indicates p-values < 0.01, *** indicates pvalues < 0.001 and **** indicates p-values < 0.0001.

The aim of this work was to develop a novel conductive polymer hydrogel
serving as an interface between an electrode and skin tissue combining the beneficial
properties of hydrogels with excellent electrical properties of PEDOT. With such
interfaces, it is important to consider a design which provides a stable, durable
interface with the tissue. To achieve this goal, we developed a fabrication method of
conductive hydrogels where the conductive hydrogel was made using commercially
available PEDOT. With this method of fabrication, conductive hydrogels were made
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with tunable mechanics and favorable electrical properties for the described
application. This method of fabrication can be adapted for a wide range of negatively
and neutrally charged polymers.
There has been significant effort to develop electrodes that eliminate the use of
a conductive interface (dry electrodes). Some of the most attractive features of dry
electrodes are their robustness and ability to adapt to body curvature. On the other
hand, dry electrodes have high impedance and do not provide a good connection
between the electrode and skin, resulting in poor signal quality. These features limit
the use of dry electrodes and thus conductive paste is used to overcome such
limitations (wet electrodes). Conductive paste dries over time, which can affect the
quality of recorded signals [43, 44]. Recent advances in the integration of materials
and electronic systems have resulted in a new generation of dry electrodes which
integrate conductive hydrogels [45-47] and conductive polymers [48] within the
electrodes. PEDOT:PSS was used as conductive interface to fabricate hydrogel-based
dry electrodes. These designs, different in their natures (electrode type and conductive
layer), improved the quality and stability of EEG signals, and enhanced the impedance
and signal-to-noise ratio of electrodes. Our conductive hydrogels are robust, similar to
dry electrodes, and provide a good connection with skin tissue as wet electrodes do.

4.4. Conclusion
In conclusion, we developed a new design to integrate a conductive interface
within an electrode that maintained a good connection with skin for successful EEG
recordings. Electrodes with alg-PEDOT hydrogel interfaces were optimized with a

118

thickness that resulted in stronger signal amplitudes than that of regular TCREs with
conductive paste. Additionally, the hydrogel-based electrodes maintained their
integrity over time. Moreover, by decreasing the electrode design’s signal-to-noise
ratio will be improved. Overall, this work shows a new fabrication approach that can
be used to integrate a conductive hydrogel interface with electrodes, creating new
designs that enhance spatial resolution for high quality electroencephalography.

Supporting information
Supporting information can be found in Appendix B.
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CHAPTER 5

CONCLUSIONS AND FUTURE WORK

5.1 Conclusions
This dissertation focused on the fabrication, development, optimization and
characterization of conductive hydrogels. Several conductive hydrogels systems were
made using commercially available conductive polymer. The method of hydrogel
production was fast and does not require specific instruments. Additionally, both
natural and synthetic polymers were used to fabricate conductive hydrogels with this
method, demonstrating the versatility in the method itself.
In the third chapter, we used the synthetic polymer polyacrylic acid to make
hydrogels at room and sub-freezing temperatures in order to fabricate conductive
hydrogels with different morphologies (macroporous and nanoporous structures). The
macroporous cryogel exhibited shape memory properties, making them suitable for
injection. Furthermore, by changing the formulation of the cryogels wide range
mechanical properties; young’s modulus between 0.2 – 20 kPa, high strain of failure
(they could endure 90 % compressive strain) and excellent toughness (above 2 kJ/m3),
were achieved. These properties are crucial to ensure the robustness and durability of
these materials. Additionally, the hydrogels exhibited sufficient conductivity to record
neural activity. Finally, the materials were biocompatible, and were loaded with and
successfully delivered protein to reduce inflammation.
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In chapter 4, we used the natural polymer alginate to make conductive
hydrogels to be incorporated into electrodes. In this work, the goal was to integrate
conductive hydrogels into a tripolar concentric electrode configuration to enhance
channel isolation, and to fabricate electrodes that can record neural activity for
prolonged periods of time. To do so, we used nanoporous hydrogels that could hold a
large amount of water within their network. The resulting alginate-PEDOT (algPEDOT) hydrogels exhibited a high strain of failure (above 80 %) and great toughness
(above 2 kJ/m3). Integration of the alg-PEDOT hydrogel into a tripolar concentric ring
configuration significantly enhanced channel isolation (about two order of magnitude).
In addition, the optimized electrode design amplified neural activity recorded with the
hydrogel-based electrodes in comparison with tripolar concentric ring electrode
(TCREs). The optimized design enhanced the signal-to-noise ratio of the electrode,
and this electrode design overcomes the limitation of using conductive paste. In
addition, the given system was found to be robust and can adapt to body curvature,
allowing the system to be more advantageous to previously-described designs.

5.2 Future work
This dissertation demonstrated a fast and easily accessible method for the
fabrication of conductive hydrogels. Many opportunities exist to conduct further
research with these materials, which may include, but is not limited to:
•

Investigation of localized protein and drug delivery using cryogels by
investigating different types of drugs and proteins that could be delivered by
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this system, which would also involve investigating the appropriate electric
and polarity properties for safe drug delivery.
•

Optimizing the mold design for TCREs by fabricating electrodes and molds as
one piece. In this manner, the electrode lead height could be reduced and the
signal-to-noise ratio could be further enhanced.

•

With the capabilities of the enhanced special resolution of TCREs and
conductive hydrogels capabilities to be fabricated in any design, targeted drug
delivery and multi-drug delivery using tripolar concentric ring hydrogel
electrodes could be further investigated.
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APPENDIX A

Supplementary Materials for Chapter 3

Graphical abstract

PEDOT-integrated cryogels exhibit porous, soft and highly compressible
mechanics and can electrically transmit neural signals. PEDOT cryogels exhibit
macroporous structures that enhance softness and compressibility which enables
injection through a 16-guage needle. Cryogel conductivity is sufficient to record EEG
signals at levels similar to traditional conductive pastes.
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Figure A1. Nanoporous PEDOT/pAAc hydrogels exhibit soft and tunable
mechanics. (a) Compressive modulus vs. acrylic acid concentration for gels
crosslinked with 1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No
gelation” indicates that there was not enough polymer and crosslinker to form a 3D gel
structure and therefore no measurement could be taken. (b) Table summarizing
statistically significant differences of moduli between different hydrogel formulations.
N = 4.
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Figure A2. The electrical properties of hydrogels are not significantly impacted
by acrylic acid and PEGDM crosslinking concentration. (a) I-V curves for gels
composed 0.26 wt% PEDOT and (i) 4 and 7 wt% AAc, (ii) 9 wt% AAc, and (iii) 10
wt% AAc. (b) Computed DC electrical conductivity for various 0.26 wt% PEDOT
hydrogel formulations when excited using (i) 0.5 V, (ii) 2 V, (iii) 4 V, and (iv) 8 V.
n.s. indicates no statistically significant differences. N = 4. Note that some gel
formulations lacked sufficient polymer and crosslinker to form stable gels.
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Figure A3. Many hydrogel formulations exhibit high strains of failure and
toughness. Strain of failure (a) and toughness (b) vs. acrylic acid concentration for
gels crosslinked with 1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No
gelation” indicates that there was not enough polymer and crosslinker to form a 3D gel
structure and therefore no measurement could be taken. For all parts, N = 4. In part (a)
the dashed line at 90% indicates that compression tests never exceeded 90% as to not
risk damaging the equipment, though no gels reached 90% compression due to failure
at lower strains.
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Figure A4. Nanoporous PEDOT/pAAc gel formulations swelled well beyond
their original volumes after casting. Ratio of swollen volume over ordinally cast
volume for PEDOT/pAAc gels vs. acrylic acid concentration for gels crosslinked with
1 wt% (red), 2 wt% (blue), and 5 wt% (green) PEGDM. “No gelation” indicates that
there was not enough polymer and crosslinker to form a 3D gel structure and therefore
no measurement could be taken. For all parts, N = 4.
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Figure A5. Nanoporous PEDOT/pAAc gel cannot survive the strains associated
with injection. (a) Compressive stress vs. strain of for a 5 x 5 cm cylindrical 9 wt%
AAc, 0.26 wt% PEDOT, 1 wt% PEGDM hydrogel, until failure (b) Photographs of a 3
x 1.25 mm cylindrical hydrogel (formulated as in part (a)) before and after injection
through a 16-guage needle.
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Figure A6. PEDOT cryogels exhibited similar DC conductivities over a wide
range of gel formulations. DC conductivity vs. gel formulation for cryogels
containing 0.26 wt% PEDOT when excited at 0.5 V (a), 2 V (b), 4 V (c), and 8 V (d).
n.s. indicates that no statistically significant differences were found (N = 4).
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Figure A7. Nyquist plots for a range of PEDOT cryogel formulations exhibit
similar characteristics. (a) Real vs. imaginary component of impedance for 4 wt%
AAc PEDOT cryogels crosslinked with 1 wt% (red) and 5 wt% (blue) PEGDM. (b)
Real vs. imaginary component of impedance for 9 wt% AAc PEDOT cryogels
crosslinked with 1 wt% (green) and 5 wt% (black) PEGDM. N = 4.
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Figure A8. Exposure to PEDOT cryogels did not visually impact the skin. Subject
forearm before gel placement (top), after 1 hour of exposure when gels (middle), and
immediately after gel removal (bottom). PAAc-PEDOT cryogel was made at 9 wt%
AAc, 1 wt% PEGDM, and 0.26 wt% PEDOT. The PAAc cryogel was made at 9 wt%
AAc, 1 wt% PEGDM, and 0 wt% PEDOT.
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Figure A9. Ethanol-treatment and autoclaving PEDOT cryogels do not
statistically alter electrical conductivity. DC electrical conductivity computed at 2 V
(a), 4 V (b), and 8 V (c) for PEDOT cryogels (9 wt% AAc, 1 wt% PEGDM, and 0.26
wt% PEDOT) before treatment (red), after ethanol-treatment (blue), or after
autoclaving (green). n.s. indicates that no statistically significant differences were
observed (N = 4).
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Figure A10. PEDOT cryogel-exposed fibroblasts do not exhibit different cell
cycles as compared to controls. Histograms of propidium iodide (PI) intensity for
fibroblasts after 10 days when not exposed to PEDOT cryogels (top row) compared to
fibroblasts exposed to PEDOT cryogels (bottom row).
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Figure A11. PEDOT/pAAc cryogel DC resistance decreases as the gel is
compressed. DC resistance vs. compressive strain for 9 wt% AAc, 0.26 wt% PEDOT,
1 wt % PEGDM cryogels. N = 4.
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Figure B1. TCR hydrogel electrode have a much better isolation between
channels. High impedance between channels indicates isolation. (A) isolation
between middle ring to center disc. Red for TCRE with Ten20 paste, blue for 2.5 mm
TCR hydrogel electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel electrode
(5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). (B)
isolation between center disc to outer ring. Red for TCRE with Ten20 paste, blue for
2.5 mm TCR hydrogel electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel
electrode (5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT).
(C) isolation between outer ring to middle ring. Red for TCRE with Ten20 paste, blue
for 2.5 mm TCR hydrogel electrode (2.5 mm TCRHE) and green 5 mm TCR hydrogel
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electrode (5 mm TCRHE) (2 wt % alginate, 2.5 mM AAD and 0.26 wt % PEDOT). N
= for all parts.
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Figure B2. TCR hydrogel electrode have higher amplitude and significantly
improves power spectrum comparing to TCRE with Ten20 paste. (A) EEG
recording from occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm
lead electrode (blue) and 5 mm lead electrode) while subject eyes were closed. (i)
Inset: zoom-in EEG recording while eyes were closed. (B) Power spectrum from
occipital lobe using TEN20 paste (red) compared to hydrogel (2.5 mm electrode lead
(blue) and 5 mm lead electrode (green)) while subject eyes were closed. (i) Inset:
zoom-in power spectra, highlighting the recording of alpha waves (8-13 Hz) while
eyes were closed. (C) EEG recording from occipital lobe using TEN20 paste (red)
compared to hydrogel (2.5 mm lead electrode (blue) and 5 mm lead electrode) while
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subject eyes were opened. Alfa wave was gone as soon as eyes were opened. (D)
Power spectrum from occipital lobe using TEN20 paste (red) compared to hydrogel
(2.5 mm lead electrode (blue) and 5 mm lead electrode(green)) while subject eyes
were open. Alfa wave was gone as soon as eyes were opened. For all parts, N = 4 at 0
hour.
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